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Abstract

DNA Double-Strand Break Mechanisms in Human Embryonic Stem Cells
By Bret Robert Adams, Ph.D.
A Thesis submitted in partial fulfillment of the requirements for the degree of Doctor of
Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2010
Major Director: Kristoffer Valerie
Professor, Department of Radiation Oncology

Central to the progression of all organisms is the maintenance of a stable genome
despite continuous insults arising from genotoxic and environmental stresses. Embryonic
stem cells show promise for treatment of a variety of diseases as well as for providing
normal human tissue to conduct scientific research. A major obstacle for their application
is that genomic instability arises in stem cells after prolonged cell culture. The most
detrimental form of DNA damage is the DNA double-strand break (DSB), which is
managed by cells through complex mechanisms, designated the DNA damage response.
There are two major types of DSB repair; homologous recombination repair (HRR) and
non-homologous end joining (NHEJ), both of which are regulated by members of the
xv

phosphatidyl-inositol-3’-kinase-related

kinase

(PIKK)

family,

including

Ataxia

Telangiectasia Mutated (ATM), Ataxia Telangiectasia Mutated and Rad3-related (ATR)
and the DNA dependent protein kinase (DNA-PK).

The aim of this study was to define the mechanisms and important proteins involved in
repair of human embryonic stem cells.

Here we have also described a system to

differentiate hESCs into neural progenitors and astrocytes and were able to examine their
DNA damage response. In both examining DNA repair markers and using a DNA repair
reporter assay, this work shows that ATR is involved in DSB repair early in development,
whereas ATM is essential in DSB repair in differentiated cells. We also show that HRR, a
high fidelity form of repair, is used extensively by embryonic stem cells and HRR
diminishes as cells differentiate. We also further defined the extent of NHEJ and the role
of high fidelity NHEJ from the embryonic to differentiated state.

These findings further the basic knowledge of repair fidelity in embryonic and mature
human tissue. The data gives insight into what proteins maintain stem cell genomic
stability and may be important to develop safe technologies for tissue engineering.
Specifically, we have defined what DNA damage signaling pathways are used as
embryologic cells progress to a mature, functional state.

xvi

xvii

Chapter 1. DNA Repair and Stem Cells

Embryonic Stem Cells

Embryonic stem cells (ESCs) are derived from the inner cell mass of an embryo
and contain unique properties that differentiated cells do not. These include a defining
property called pluripotency, which describes their ability to form all three germ layers of
the human body: the ectoderm, endoderm and mesoderm. During embryonic development
ESCs differentiate into adult stem cells and fully differentiated cells. Adult stem cells or
progenitor cells are said to be multipotent indicating that they can develop progeny of
several different cell types including cardiac (Fleischmann et al. 1998), endothelial (Wang
et al. 1992), or neuronal cells (Dhara et al. 2008a). Throughout differentiation cells gain
more specialized functions. The final stage of differentiation is to form somatic cells from
multipotent cells containing specialized functions such as neurons which transmit electrical
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signals or muscle cells acting as contractile tissue. These unique properties of stem cells
indicate they are a potential tool for advancement in regenerative medicine, the
understanding of developmental biology, drug development and other applications
(Thomson et al. 1998). As stem cells replicate they are capable of either symmetric
(clonogenic) or asymmetric fission (Figure 1-1). Symmetric division generates a self-renewing
supply of pluripotent ESCs, while asymmetric division produces one cell identical to the parent
ESC and a differentiated cell.

ESCs are able to self renew indefinitely and there are several possible cellular
processes that make this possible. Unlike somatic cells, ESCs maintain their telomere
length indefinitely by expression of telomerase (Carpenter et al. 2004). Senescence may
also be avoided in ESCs by a mechanism dependent on a non-functional p53 pathway
(Miura et al. 2004), or by fundamental differences in the ability of hESCs to prevent and
repair DNA damage (Adams et al.; Maynard et al. 2008).

Telomeres are repetitive sequences containing the nucleotide sequence TTAGGG,
which functions to preserve the structure of the end of each chromosome. Telomeres act as
a capping mechanism that prevents the ends of the chromosomes from being chewed back
by exonucleases and distinguishes them from double-strand breaks (Lundblad 2000). As
cells divide the length of the telomere decreases unless the cells express telomerase which
extends these structures. Telomerase is expressed in ESCs, germ line cells,
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and cancer cells but not in somatic cells. Since it is not expressed in somatic cells the
telomere shortens and may act as a clock to signal when cells should stop dividing.

The p53 transcription factor has also been shown to be important in differentiation
and may act as a negative regulator of pluripotency. p53 is known as the “guardian of the
genome” and regulates genomic stability and growth through several mechanisms. p53
can stimulate DNA damage response, induce cell cycle arrest at the G1/S transition, or
initiate apoptosis, a mechanism for programmed cell death (Abraham 2001). In examining
a role in differentiation it was shown that p53 can control transcription of the genes
required for ESC self renewal (Lin et al. 2005; Maimets et al. 2008). Importantly increased
expression of p53 may mediate differentiation whereas its knockdown can help lead to
dedifferentiation of somatic cells (Hong et al. 2009). A recently generated p53 hESCs
knockout line has been generated and shown to diminish the G2/M checkpoint indicating a
role in genetic stability (Song et al.).

ESCs sustain their pluripotency and bypass senescence unlike somatic cells and an
explanation for this is these cells are able to maintain their genomic and epigenetic
integrity to a higher degree than somatic cells (Hong et al. 2007). However the effects of
stress such as radiation, hypoxia, and stress-induced senescence on human ESCs (hESCs)
are not clearly defined.

4

It was not until recently that the isolation of hESCs from the blastocysts was
successfully performed and these cells could be propagated in vitro (Thomson et al. 1998).
For this reason the DNA damage response has only been studied in immortalized somatic
cells and cancer cells. Investigating repair in these cells is important since ESCs form all
tissues of the embryo indicating that these few cells must stringently avoid any
proliferation of mutations arising during embryogenesis.

DNA Damage and Repair

DNA damage can be caused by a variety of endogenous and exogenous agents
including UV light, chemical carcinogens, reactive oxygen species, chemotherapeutic
reagents and various forms of radiation (Hall 2000,(Norbury and Hickson 2001). Harmful
agents cause many different forms of DNA damage as well. Each of the nucleic acid bases
can be covalently modified at various positions leading to base substitutions and alterations
of the genetic code. A DNA strand can also covalently bind itself or the opposite strand,
which is known as intrastrand and interstrand cross-linking, respectively. Here, mistakes
are made during the DNA replication leading to improper base pairing, deletions or
insertions. Also, the backbone strand itself can be broken leading to either single-strand
or double-strand breaks. Repair of each form of damage can be accomplished by specific
cellular processes with the possibility of overlap between proteins used in each mechanism
(Jackson 1996; Matsuoka et al. 2007).
5

When a cell endures DNA damage there is a multifaceted response to counter the
effects of damage. Once the genomic injury has been detected several cell cycle
checkpoints are activated to prevent further progression in order to allow time for repair
before further cellular division. Here the decision is made to either repair the damage or
undergo apoptosis (Norbury and Hickson 2001). Therefore, the DDR can stimulate or
inhibit gene transcription of major DNA repair and apoptotic proteins depending on the
level of the damage.

The DNA checkpoints utilize sensor proteins as the initial signaling elements that
respond to strand breaks, partially replicated DNA and base modifications (Jackson 1996).
These sensors quickly moderate the actions of downstream proteins. Human cells contain
three well classified proteins implicated in damage sensing from the phosphatidyl-inositol3’-kinase-related kinase (PIKK) family of proteins. These proteins are ataxia
telangiectasia mutated (ATM), ATM and Rad3-related (ATR) and DNA dependent protein
kinase (DNA-PK)(Jackson 1996).

ATM and ATR are thought to share responsibilities as the apical protein kinases in
all of the known cell cycle checkpoints. These proteins share sequence homology in the
catalytic domains as well as a similar overall structural organization (Abraham 2001). Both
of these proteins contain FAT/FATC domains which do not correlate to any known
catalytic domain, however they most likely regulate intramolecular conformation. An
6

analysis of proteins phosphorylated in response to DNA damage shows conserved sites
recognized by ATM and ATR. Interestingly the p-(S1981)ATM antibody has been shown
to identify multiple proteins due to the conserved sequence that is phosphorylated by both
ATM and ATR, therefore the p-ATM antibody may recognize substrates downstream of
ATR as well (Matsuoka et al. 2007).

While ATM and ATR share many responsibilities, understanding the checkpoint
responses can begin to separate each kinase’s role in genomic stability. The G1 checkpoint
is controlled by p53. When p53 is phosphorylated at serine 15 it upregulates p21, a cyclin
dependent kinase inhibtor that suppress cyclin E/A, which cause the G1 to S transition
(Figure 1-2). ATM has been shown to be responsible for the early response and the initial
activation of p53, whereas ATR may aid in maintenance of p53 activation at later time
points, however ATR is less significant in this pathway. It is also important to note that
ATM activates CHK2 which relays the signal for MDM2 to release p53 in order for the
checkpoint to be robust.

The S-phase checkpoint is signaled through several mechanisms including one in
which ATM activation leads to the proteosome-mediated degradation of Cdc25A and then
failure to maintain activation of cyclin complexes thereby halting synthesis. ATR’s role in
this checkpoint is associated with signaling after replication fork stalling. Here ATR may
activate a variety of factors including Chk1 and Rad protein family members, which detect
and act as scaffolding at points of DNA damage.
7
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Figure 1-2. Cell cycle checkpoint control after DNA damage.
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allowing the cell time to repair itself or induce apoptosis. The three
main cell cycle checkpoints occur at the G1/S transition, within S
phase, and at the G2/M transition. Adapted from Robert Abraham
(2001)
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The G2 checkpoint utilizes ATR and Chk1 as its central signaling mechanisms. Initiation
of the G2/M checkpoint begins with activation of Chk1, which phosphorylates the mitosispromoting phosphatase, Cdc25C. Phosphorylation of Cdc25C by pCHK1 creates a binding
site for 14-3-3 proteins ultimately inactivating Cdc25C. Therefore Cdc25C is unable to
dephosphorylate and hence activate cyclin B·Cdc2 kinase, a complex responsible for G2 to
M progression. Deficiency in any of these proteins responsible for sensing or relaying the
DDR will lead to cancer predisposition (Thompson and Schild 2002). As mentioned
previously ATM and ATR kinases have some functional redundancy and are possibly able
to signal through each checkpoint in the absence of the other. Notably A-T cells, which
have a nonfunctional ATM protein, exhibit strong G2 checkpoint arrest regardless of the
type of damage. This indicates ATM is not essential for the G2 checkpoint and likely points
to ATR for policing this checkpoint (Beamish and Lavin 1994).

Double-Strand Break Repair

It has become increasing clear that the most detrimental form of damage to DNA is the
double-strand break (DSB) (Iliakis 1991). Accordingly, one DSB may lead to cell death if
left unrepaired (Dasika et al. 1999). It is important to note that normal metabolic
intermediates and stalled replication forks can induce these breaks. In fact, DSBs are
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Povirk (2003) and Iliakis (2009)
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needed in the normal physiological cellular processes in the production of antibodies
during V(D)J recombination (Bassing et al. 2002).

Essential to the cell are two forms of DNA DSB repair referred to as nonhomologous end joining (NHEJ) and homologous recombination repair (HRR). NHEJ
represents in its simplest form an error-prone repair of the DNA break and is the
predominant type of DSB repair in mitotically dividing cells. NHEJ begins with the
KU70/KU80 heterodimer binding to the DNA ends which recruits the catalytic subunit of
DNA-dependent protein kinase (DNA-PKcs). The ends are resected by the Artemis and
MRE11/RAD50/NBS1 (MRN) nucleases, followed by XRCC4, XLF and DNA ligase IV
recruitment for resealing (Povirk 2002; Valerie and Povirk 2003; Ito et al. 2004) (Figure
1-3). Also the utilization of this dominant pathway of NHEJ (D-NHEJ) may allow for
enzymes such as polymerases µ and λ to fill in nucleotide overhangs and ensure a higher
accuracy of repair (Akopiants et al. 2009).

New evidence is further defining backup NHEJ (B-NHEJ) pathways and indicates
there are multiple signaling components. NHEJ may utilize a dominant pathway with the
components previously mentioned including DNA-PKcs, Ku 70/80 and LigIV/XRCC4,
while a backup pathway may utilize Histone H1, Poly (ADP-ribose) polymerase 1 (PARP1), and a Ligase III/XRCC1 complex (Figure 1-3). Through knockout studies in MEFs it
appears the back-up pathway for NHEJ has slower repair kinetics (Iliakis 2009) and occurs
in the S/G2 phase of the cell cycle (Iliakis 2009). Current models show that Ku70/80
11

binds DNA DSBs with higher affinity and faster kinetics than components of the back up
pathway, thereby inhibiting this process (Wang et al. 2006). However, when the dominant
DNA-PKcs dependent form fails due to low levels of essential protein components or
changes in chromatin structure, the back-up pathway is utilized. Also the utilization of the
backup pathway with slower kinetics may allow for enzymes such as polymerases µ and λ
to fill in nucleotide overhangs and ensure a higher accuracy of repair. There is current
speculation high fidelity NHEJ may be more common in S or G2 cells due to the presence
of a sister chromatid. There is data showing close physical cohesion of sister chromatids
might play an important role in stabilizing the ends of the DSB and preventing degradation
or exonuclease activity that may lead to deletions (Miyazaki and Orr-Weaver 1994).

Homologous recombination repair uses a DNA template, either in the form of a
sister chromatid, homologous chromosome or repeated sequence, to ensure high-fidelity
repair. This mechanism involves a large number of proteins, including RAD51, its paralogs
(XRCC2, XRCC3), RAD52, RAD54, BRCA1, BRCA2, and the MRE11/RAD50/NBS1
complex (Karran 2000; Thompson and Schild 2001) (Figure 1-4). After the break there is
resection of the DNA on each side of the DNA duplex. RAD51 then binds this singlestranded DNA and this complex begins “strand invasion,” a term signifying the search for
a homologous sequence. After strand invasion a polymerase will extend the invading
strand and form what is known as a Holliday Junction. After cleavage of the Holliday
junction DNA synthesis occurs to restore the strand on the homologous chromosome that
was displaced during the strand invasion. Whereas NHEJ can occur throughout the cell
12
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cycle, it is believed that NHEJ is predominant in G1, whereas HRR is predominant during
late S and G2 phases when sister chromatids are available (Rothkamm et al. 2003).

Ionizing Radiation

Ionizing radiation (IR) consists of subatomic particles that are able to detach
electrons from atoms or molecules. The ability of electromagnetic radiation to ionize
particles depends upon its wavelength, hence the energy it carries (Camphausen and Coia
2009). Paradoxically, IR can induce cancer as well as be used to cure it and while
radiation has many effects on the cell, the most significant biological target is the DNA.
Radiation doses are defined as the energy absorbed per unit mass which is equivalent to 1
J/kg and given the name Gray (Gy). Depending on the form of radiation the particles can
have direct action on DNA or indirect actions by the formation of hydroxyl radicals, which
contain an unpaired electron eager to react with another molecule (Hall 2000). Notably as
cells differentiate or proliferate at slower rates they become more radioresistant (Figure 15).

DNA Damage Response Proteins

ATM, ATR and DNA-PKcs, represent proteins that are crucial for preventing the
acceleration of aging, senescence, premature death and are associated with the
maintenance of telomeres and genomic stability (Wong et al. 2003; Espejel et al. 2004).
14
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Mutation of each of these proteins helps define what roles they may play in the human
body.

Mutation of the ATM gene leads to the disease A-T, which is characterized by
immunodeficiency, a wobbly gait, cancer sensitivity and sterility (Shiloh 1997). These
cells are most notable for their high radiation sensitivity (Dasika et al. 1999). ATR is an
essential gene indicating the embryo will not survive with it being absent (Brown and
Baltimore 2000). When ATR is mutated at specific residues that lead to a splicing
deficieny and therefore a decreased amount of the normal protein, a disease named Seckel
syndrome results (O'Driscoll et al. 2003). This disease is characterized by growth
retardation and “bird like” features with many phenotypes related to premature aging.
Also, individuals with DNA-PK mutations experience severe combined immunodeficiency
with an absence of B and T cells and similar to A-T patients these individuals also have
sensitivity to IR (Collis et al. 2005).

PARP-1 binds to DNA at certain damage sites and catalyses the formation of
polyADP-ribose (PAR) on itself and other acceptor proteins (Lindahl et al. 1995). PAR
formation is believed to alter chromatin structure, protect sites of DNA breaks and attract
repair proteins. While knockout of either ATM or PARP-1 by themselves does not result in
lethality, there is lethality when there is dual knockout of these genes. This suggests that
these genes may act in parallel pathways or backup to each other when DNA is faced with
harmful DNA breaks. It has also been shown that ATM and DNA-PK function on the
16

same pathway to ensure cellular survival in the absence of the PARP-1 gene (Bryant and
Helleday 2006).

Regenerative Medicine

Although stem cell transplantation may offer treatments for many debilitating
diseases, some concerns have been raised over its safety. A major problem when
propagating human embryonic stem cells (hESCs) in vitro is the inability to preserve
genomic stability. Several reports show that hESCs propagated in vitro for even a few
months can develop an abnormal karyotype (Buzzard et al. 2004; Draper et al. 2004).
Avoiding chromosomal rearrangements and mutations is imperative for tissue engineering
and human therapy with cells derived from embryonic or adult stem cells. This has become
apparent by reports of donor derived leukemia after hematopoetic stem cell transplant as
well as brain tumors due to implanted neural stem cells (Eguchi et al. 2001; Amariglio et
al. 2009). This technology is clinically promising yet detrimental when the cells do not
maintain genetic stability. Embryonic stem cells seem to have unique properties when it
comes to the DNA damage response (DDR) and DNA repair critical for maintaining
genomic stability. Thus, it is very important to understand these properties in ESCs and
neural progenitor (NPs) cells to ensure that cells are faithfully propagated in vitro for
human tissue regenerative purposes.
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Chapter 2 Neural Differentiation of Human Embryonic Stem Cells

Introduction

Human embryonic stem cells have recently been isolated from the human
blastocyst and been shown to grow in culture while maintaining their pluripotency
(Thomson et al. 1998). There has been a strong interest in developing methods to direct
these cells down a specific cell lineage in order to obtain a virtually endless supply of
functional human primary cells. Recent reports have explained methods for directing these
cells down to neural progenitors (NPs) (Dhara et al. 2008b). Similarly other investigators
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have shown the ability to grow in vivo derived NPs in cell culture and differentiate them to
astrocytes in vitro (Seth et al. 2004). Here we examined the proper markers for hESCs as
the cells were guided to NPs and astrocytes as well as neurons. Similarly we show that
there is a loss in proliferation once cells have reached terminal differentiation.

Characterization of hESCs can be performed through staining of different proteins
involved in pluripotency. Oct3/4 is a transcription factor within the cell nucleus controlling
key pathways involved in proliferation and pluripotency. It has been shown to be quickly lost
by differentiating hESCs and is the standard to monitor the maintenance of pluripotency in in
vitro conditions (Pan et al. 2002). When losing pluripotency, the cells must commit down a
lineage to form a specific precursor cell from one of the three germ layers. NPs can be
identified by maintenance of the markers Nestin, Musashi-1 and Sox2. Nestin is expressed

during development and is down regulated into adulthood in all cells except for those in
the subventricular zone in the brain. This portion of the brain is where NPs reside and
divide. As an exciting step towards regenerative therapy hESC derived NPs can be
implanted in mouse brains, migrate along developmental tracks in the brain, differentiate,
and use local cues to participate in the normal brain (Reubinoff et al. 2001). NPs in the
subventricular zone express Nestin which is a type VI intermediate filament protein
replaced upon differentiation by other tissue-specific intermediate filament proteins. Sox2
is a transcription factor controlling many of the genes involved in multipotency and is
expressed in NPs and hESCs. Notably to distinguish NPs from hESCs there is an increase
in the expression of Musashi-1 as cells progress to NPs and a decrease after terminal
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differentiation. Musashi-1 is a RNA binding protein that helps maintain multipotency by
many mechanisms including regulating Notch signaling, a pathway involved in differentiation
(Sakakibara et al. 1996; Okano et al. 2005).

Astrocytes have many roles in the central nervous system. These roles include
structural support, contribution to the blood-brain barrier, and nervous system repair. They also
are involved in neural transmitter reuptake in order to regulate the ionic balance, which
preserves neuronal health (Anderson and Swanson 2000; Wilczynska et al. 2009). These
cells express glial fibrillary acidic protein (GFAP) which replaces Nestin as an intermediate
filament (Pekny and Pekna 2004). GFAP’s function is not clearly delineated; however it is
believed to be involved in mechanical strength and maintaining the shape of astrocytes.

NPs also have the ability to differentiate into neurons and oligodendrocytes. Neurons
transmit information and react to stimuli through electrochemical signaling and
neurotransmitter release while oligodendrocytes function to myelinate axons thereby
improving signal transduction. Neurons can be identified by a cytoskeletal protein called β-III
tubulin, while mature oligodendrocytes are distinguished by expression of O1 protein (Sommer
and Schachner 1981). As cells reach terminal differentiation several phenotypic changes will
result including a decrease in the nuclear to cytoplasmic ratio and the development of
cytoplasmic extensions (Wilczynska et al. 2009).

As cells progress through differentiation there will also be a loss in cell
proliferation (Nieoullon et al. 2005). Experimentally, in order to validate a decrease in
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growth 5-bromo-2-deoxyuridine (BrdU) can be used, which is a synthetic nucleoside
analogue of thymidine. BrdU is incorporated into newly synthesized DNA as cells progress
through DNA synthesis in the place of thymidine. Antibodies directed against BrdU can
then be used to detect the incorporated chemical and thus quantify cells that were actively
replicating their DNA.

Materials and Methods

Antibodies and reagents

Antibodies used were anti-Oct3/4 and anti-β-actin from Santa Cruz Biotechnology
(Santa Cruz, CA), anti-Nestin, anti-GFAP, anti-Musashi1, anti-βIII tubulin, anti-O1 and
anti-Sox2 from Chemicon/Millipore (Billerica, MA), and anti-BrdU from Abcam.

Cell culture and treatments

BGO1V cells are embryonic stem cells that are easier to culture than BGO1 cells
without inadvertently causing cell differentiation. They are a derivative of BG01 cells with
karyotypic abnormalities (49, +12, +17 and XXY) which retain embryonic stem cell
markers and characteristics, and the ability to differentiate down a neural lineage (Dhara et
al. 2009). Differentiation was performed to according to published protocols to obtain
populations of NPs and astrocytes (Fig. S1) (Adams et al.; Lawrence et al. 2006;
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Wilczynska et al. 2009). Briefly, BG01V cells were cultured in ES medium as described in
(Shin et al. 2006; Wilczynska et al. 2009) consisting of Dulbecco’s modified Eagle’s
medium (DMEM)/F12 medium (GIBCO, Grand Island, NY) supplemented with 20%
knockout serum replacement (KSR) (GIBCO), 2 mM L-glutamine, 0.1 mM non-essential
amino acids, 50 U/ml penicillin, 50 µg/ml streptomycin, 0.1 mM β-mercapto-ethanol, and
5 ng/ml basic fibroblast growth factor (b-FGF) (R & D Systems, Minneapolis, MN). Cells
were expanded on dishes of lysed MEF feeders (Gospodarowicz et al. 1980).

Derivation of NPs was performed as described (Shin et al. 2006). Briefly, NP cells
were grown on laminin coated dishes in DMEM/F12 medium containing 15% FBS and 5%
KSR followed by an additional 7 days in media containing (DMEM/F12, N2 supplement
(GIBCO), penicillin/streptomycin, L-glutamine, 5 ng/mL of b-FGF, and 10 ng/mL
leukemia inhibitory factor (LIF). The cells were cultured in DN2 media for an additional 7
days to obtain the NP population. NPs were propagated on poly-ornithine- and laminincoated plates in Neurobasal A Medium (GIBCO) supplemented with B-27 (GIBCO), Lglutamine, and penicillin/streptomycin, 20 ng/mL b-FGF, and 10 ng/mL of LIF. Astrocytes
were obtained by exposure of NPs to DMEM and FBS for 25 days on laminin-coated
plates as described (Lawrence et al. 2006; Wilczynska et al. 2009).

BrdU Staining
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Cells were grown on glass chamber slides. After the specified time of exposure to
BrdU, cells were fixed with 3% paraformaldehyde for 15 min at room temperature. Cells
were exposed to 2 N HCl for 30 min at 37oC, washed with PBS and a neutral pH was
established by incubation with 0.8 M Borax for 10 min at RT. Cells were permeabilized
with 0.5% Triton X-100 and then blocked with 0.5% goat serum in 10% milk followed by
the addition of anti-BrdU antibody (1:100) to each chamber and rocked at +4oC overnight,
washed, and incubated with secondary anti-rat Alexa 488 antibody (1:500). Finally, cells
were washed in PBS and nuclei counter-stained with 4',6-diamidino-2-phenylindole
(DAPI).

Immunocytochemistry

Immunocytochemistry (ICC) imaging has been described previously (Golding et al.
2007). Cells were grown on Lab-Tek (Naperville, IL) glass slides. After treatment, cells
were fixed with 3% paraformaldehyde for 15 min at RT, permeabilized with 0.5% TritonX-100 in phosphate-buffered saline (PBS) for 10 min at RT and blocked with 10% non-fat
dry milk/0.5% goat serum/PBS prior to exposure to primary antibodies. Subsequently,
cells were incubated with primary antibodies at dilutions of 1:500 or isotype control
nonspecific sera (Chemicon) overnight at 4°C in the blocking solution, followed by
incubation with secondary antibodies Alexa 488 goat anti-rabbit or goat anti-mouse 546
F(ab) fragment (Invitrogen) at 1:500 dilution, and nuclei counter-stained with DAPI at 1
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μg/mL. Cells were imaged and analyzed using a Zeiss LSM 510 Meta imaging system in
the Massey Cancer Center Flow Cytometry and Imaging Facility with 63x or 100x
objectives using the appropriate laser excitation of 405, 488, or 543 nm depending on the
secondary antibody used. Band pass filters for these three channels used were 420-480
nm, 505-530nm, and 549-613 respectively. A 0.5 µm slice of the nuclei was taken.
Resolution of the images was set at 1044x1044 pixels per image.

Results

BG01V cells differentiate down a neural lineage to form neural progenitors and then
astrocytes.

hESCs, NPs and astrocytes were propagated and examined for differentiation
markers. The hESCs were positive for Sox2, Nestin, slightly positive for Musashi-1, and
negative for GFAP. >95% of these hESCs were positive for Oct3/4 (Figure 2-1). These
proteins correctly stained for by antibodies and located in the cell’s nucleus or the
cytoplasm according to each proteins function as transcription factors (nucleus), mRNA
binding protein (cytoplasm) or as cytoskeletal proteins (cytoplasm). This can be observed
as either co-staining with the nucleus (DAPI) or as staining around the nucleus signifying
the cytoplasm. 90% of the NPs stained positive for Sox2, Nestin, and Musashi-1 and were
negative for Oct3/4 and GFAP (Figure 2-1). The astrocytes were slightly positive for
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Figure 2-1. BG01V cells are directed down a neural lineage to
form neural progenitors and terminally differentiated astrocytes.
(A) hESCs, (B) NPs and (C) astrocytes were incubated with the
indicated antibodies. Top row in each set shows staining without
DAPI and bottom row the same fields with DAPI.
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Musashi-1 and negative for all other markers except around 95% of the cells were positive
for GFAP (Figure 2-1).

This directed differentiation protocol produces cells with other phenotypic
characteristics of astrocytes. As cells progress from hESCs to NPs and then to astrocytes
there is a significant increase in the amount of glutamate uptake by the cells. Also there is
increased mRNA expression of GFAP and SPARCL1, which again are markers for
terminally differentiated astrocytes (McKinnon and Margolskee 1996; Wilczynska et al.
2009). Also as cells become astrocytes they obtain cytoplasmic projections and a decrease
in the nuclear to cytoplasmic ratio.

Neural progenitor’s differentiation into neurons or oligodendrocytes is insignificant.

It has been well established that hESCs can be differentiated into NPs (Shin et al.
2006). However in vitro differentiation of NPs to astrocytes had previously only been
performed on in vivo derived progenitor cells. Therefore it was necessary to quantify what
percentage of NPs were differentiating into the other CNS cells besides astrocytes. We
examined whether the cells were forming neurons or oligodendrocytes by staining with the
neuronal marker β-III tubulin and the oligodendrocyte marker O1. The differentiation
shows only 1-2% of cells differentiate into neurons which contain a different morphology
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Figure 2-2. BG01V cells do not differentiate into neurons and
oligodendrocytes. Cells were stained for the marker βIII-tubulin
(neuronal specific) and for O1 (oligodendrocyte-specific). To
demonstrate the presence of βIII-tubulin+ cells a non-representative
field of the population is displayed.
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than the astrocytes. β-III tubulin positive cells are flat with extended projections like
astrocytes, except these cells contain curled over nuclei (Figure 2-2) The differentiation
scheme did not produce any oligodendrocytes which is shown by the lack of O1 protein
expression.

Cells lose the ability to proliferate after differentiation

To determine the proliferation rate of hESCs and astrocytes cells were incubated
with BrdU and its uptake was monitored to analyze cell proliferation. Here we are able to
see that in only 6 hrs of incubation roughly 40-60% of the hESCs have been in or are in S
phase. However after 6 hours of incubation of astrocytes approximately 3-4% of the cells
incorporate BrdU (Figure 2-3). Therefore there is a drastic decrease in the proliferation
rates from the early embryonic stage to the mature differentiated cells.

Discussion

Understanding the processes controlling neural cell differentiation may have
critical consequences for therapies of brain tumors and regenerative medicine. Although
research on the aspects DNA repair in mammal ESCs provides understanding of the
processes, many differences exist between the human system and rodents including
expression levels of major repair enzymes, repair kinetics and the efficiency of the DNA
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damage checkpoints (Hornsby 2003; Banuelos et al. 2008). Here we combined several
protocols in order to generate NPs and then astrocytes in vitro from hESCs.

The hESCs showed the correct staining for the pluripotent marker Oct3/4 defining
its ability to form any cell of the three germ layers, as well as several other markers for
multipotency. Similarly, NPs were identified by maintenance of these markers except for
the loss of Oct3/4 and gain of Musashi-1. Astrocytes were obtained at hiugh levels as
denoted by GFAP+ staining.

There is also a strong correlation between differentiation and the loss of the ability
to proliferate. Here through BrdU staining it is possible to see that virtually none of the
astrocytes are in S phase. It is also likely that the very small percentage of cells, 3-4%, that
are dividing are astrocytic or glial precursor cells. It was important to check whether there
is variation into which cell types glial precursor cells would differentiate. O1 and β-III
tubulin staining showed that these cells were not forming neurons or oligodendrocytes. It
is possible to generate a higher percentage of neurons from the NPs but they must be
exposed to additional growth factor during the differentiation process (Zhang et al. 2001).
It also important the DNA repair assays used in this work require flat nuclei in vitro to
track the resolution of DNA damage therefore the neuronal cells, which contained folded
nuclei, could not be used.
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Altogether, relatively pure populations of hESCs (>95%), NPs (>90%), and
astrocytes (>95%), were isolated and propagated. Importantly the cells show phenotypic as
well as functional property of astrocytes such as glutamate uptake (Wilczynska et al.
2009). With these relatively pure populations of astrocytic cells at three different points of
development we are able to then study the important aspects of DNA repair in models of
early embryologic tissue to mature adult CNS tissue.
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Chapter 3 DNA Damage Responses in hESCs

Introduction

Several studies show there is an increased importance for HRR early in
development. Initial attempts to study such consequences were hindered by the embryonic
lethality of knocking out a number of genes expressing proteins critical for HRR. The
developmental significance was first displayed by knocking out RAD54, a protein
involved in HRR, in mice which became sensitive to IR at the embryonic stage but not at
the adult stage (Essers et al. 2000). Interestingly, DNA-PKcs-deficient SCID mice become
hypersensitive to IR when crossed with RAD54-/- mice. More recently, mice with the
critical HRR factor XRCC2 deleted also showed embryonic lethality and significant
apoptosis early in fetal development (Orii et al. 2006). The apoptotic events in these mice
were exclusively located in the ventricular zone where neural stem cells develop. Also,
mice deficient in Ligase IV, essential for NHEJ, showed no significant consequence until
mid- to late-stages of embryonic development. Unlike XRCC2-/- mice, those cells that
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showed apoptotic events stained positive for a marker indicating they were undergoing
differentiation (Orii et al. 2006). Also from these studies, it was determined that MEFs
derived from XRCC2-/- mice exhibit spontaneous chromosomal rearrangements in culture
(Orii et al. 2006).. Altogether, these studies suggest that HRR is critical during early
development, whereas NHEJ is more important at later stages. Because the repair
pathways have such an imperative role in determining whether a cell will reach a
functional and physiologic state as it differentiates, it was important to examine kinetics of
DNA repair throughout differentiation.

Our laboratory utilizes ionizing radiation (IR) as a method for induction of DSBs.
Several antibodies will be used to verify the repair efficiency of irradiation induced foci
(IRIF), which represent the collection of repair proteins at the site of a double-strand break.
dEpigenetic alteration of histone variant 2AX by phosphorylation at serine 139 is one of
the earliest signs of formation of DSBs (Rogakou et al. 1998). This alteration is designated
γ-H2AX. This marker can define one DSB and yield over 2000 γ-H2AX molecules with
the chromatin modified up to 2 megabases away from the damage site. It is important to
note that H2AX phosphorylation occurs during mitosis and apoptosis in both normal
human and cancer cell lines indicating that on rare occasion it may not signal for a DSB
(Rogakou et al. 2000). While this phenomenon has yet to be observed in stem cells other
DNA repair proteins that are involved in foci formation must be examined to validate any
conclusions.
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In order to specifically look at HRR repair foci RAD51 localization can be
examined since this protein plays a pivotal role in the HRR pathway. RAD51 is a
scaffolding protein that has been shown to colocalize with both tumor suppressor proteins
BRCA1 and BRCA2 in DNA-damage-induced foci. Studies have shown that HRR is a
delayed process and for this reason it is important to examine foci repair at time points up
to 24 hrs. 53BP1 represents a factor involved in the DNA DSB repair response forming
foci that colocalize with γ-H2AX within 5 minutes of IR treatment (Schultz et al. 2000).
The recruitment of 53BP1 is independent of ATM, however it does require the
phosphorylation of histone 2A (Ward et al. 2003). DNA-PKcs represents the core complex
of proteins responsible for NHEJ and we have currently utilized an anti-p-(T2609) DNAPK to determine the presence of IRIF in glioma cells (Golding et al. 2009a). The use of
several antibodies to repair foci is an efficient manner in validating their resolution and for
depicting which repair process may be more prevalent.

These assays will establish which form of DSB repair is occurring and at what rate
there is resolution of DSBs. This will be determined as cells age from the embryonic to
differentiated state. This method displays changes in repair rates by tracking the resolution
of DSBs, however the proteins are surrogate markers of the break and are not definitive in
displaying restoration of the break.
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Materials and Methods

Antibodies and reagents

Primary antibodies used for staining were anti-γ-H2AX (S139) (Millipore, MA),
anti-p-(S1981)-ATM (Cell Signaling, Beverly, MA), anti-RAD51 (EMD Biosciences),
anti-53BP1 (BD Transduction Laboratories).

IRIF assay

Performed as described in Chapter 1. Foci were quantified by manual counting and
the Cell Profiler Software (www.cellprofiler.org). Irradiations were performed using an
MDS Nordion Gammacell 40 (ON, Canada) research irradiator with a Cs-137 source
delivering a dose of 1.05 Gy/min.

Cell Cycle Analysis

DNA content was determined by propidium iodide (PI) staining. Cells were
trypsinized and fixed with 70% ethanol for 24 h at 4oC. Cells were resuspended in PI stain,
4mM Sodium Citrate, 5 μg/mL PI, 0.1% Triton-X-100 and RNase A. Cells were analyzed
on a Coulter Epics XL MCL flow cytometer at the Massey Cancer Center Flow Cytometer
Facility.
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Flow Cytometry

γ-H2AX flow cytometry was performed on cells fixed in 70% ethanol overnight at
4 oC prior to staining. Cells were resuspended in 1% FBS/PBS and incubated with anti-γH2AX (1:1000) for 1 hr in PBS 0.1% triton-X, washed, and exposed to anti-mouse Alexa
488 antibody (1:1000). After washing the cells were put in PI stain (5 µg/mL in 0.1%
Triton-X/PBS) and passed through a 50μM nylon mesh filter. Gating functions were used
and applied to a 2-D plot of side scatter versus forward scatter to analyze live cells. γH2AX+ cells were determined by gating a 2D plot of green fluorescence (γ-H2AX) versus
red fluorescence (PI). Data were analyzed using EXPO32 ADC softwareTM (Beckman
Coulter).

Western blotting

Protein lysates were prepared by scraping cells and pelleting of cells in PBS before
addition of Laemmli lysis buffer (BioRad). Lysates were sonicated for 30 sec and boiled
for 10 min. Proteins were separated by sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE). Cells were separated with a 4% stacking gel and then a
resolving gel based on molecular weight of the protein. Proteins <150 kDa were resolved
at 10% acrylamide while proteins >150 kDa were resolved at 5% acrylamide. Gels were
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run at 110V at room temperature and transferred to polyvinylidene difluoride (PVDF) for
10% gels or nitrocellulose membranes for 5% gels. 10% gels were transferred in TrisGlycine buffer at 0.6 amps (A) for 2 h, while 5% gels were transferred at 0.1 A overnight.
Membranes were blocked in casein for 30 min and exposed to antibodies at 1:200-2000
dilutions. Membranes were washed in PBS/0.1% Tween 20. Specific protein bands were
detected and quantified using infrared emitting-conjugated secondary antibodies; antirabbit IRDYE 800 (Rockland Immunochemicals, Gilbertsville PA) or anti-mouse Alexa
680 (Invitrogen) using the Odyssey infrared imaging system from Li-Cor Biosciences
(Lincoln, NE). Densitometry of immunoreactive band was performed using the Odyssey
Application Software version 1.2 from Li-Cor Biosciences (Lincoln, NE).

Statistics

Unpaired two tailed t-tests were performed on triplicate data sets using GraphPad
Prism 3.0 (GraphPad Software, Inc). P-values are indicated as * <0.05, **<0.01,
***<0.001, ns=not significant.

Results

Irradiation dose response kinetics of hESCs
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characterizing DSB repair in hESCs. A dose response curve was generated to show the
effects of irradiation on hESCs. Cells were grown in chamber slides and treated with 0.1,
0.5, 1, 2, 5 Gy. The number of foci per nuclei was counted and plotted. Phosphorylation
of ATM at S1981 is often used as a sensitive surrogate for DSB repair in cancer cells
(Golding et al. 2007), however, the antibody might recognize other cross-reactive proteins
with a similar p-(S-T/Q) motif as p-S1981 ATM (Matsuoka et al. 2007). Nevertheless, pATM IRIF appeared in a dose-dependent manner (Figure 3-1A and B), as did γ-H2AX and
53BP1 IRIF at doses as low as 0.1 Gy (Figure 3-1B), suggesting that at least superficially
hESCs behave similar to human cancer cells. The radiation dose response of DSBs was
linear between 0.1 and 2 Gy (Figure 3-1B) and there was also a low background of foci in
these cells.

γ-H2AX staining occurs through out the cell cycle

In order to establish that γ-H2AX would be a suitable marker for quantification of
the DSB repair kinetics its activation by irradiation across the cell cycle was analyzed. The
drugs and treatments that were used throughout these studies have been shown to have
effects on the cell cycle since it is intertwined with the DNA damage response. Here
hESCs were irradiated with 0, 2, 5, or 10 Gy and among treatment groups there was an
equal increase in γ-H2AX staining across the cell cycle as shown by propridium iodide
staining (Figure 3-2).
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Figure 3-1. Characterization of DSB formation in hESCs. (A)
Depicted is immunostaining of hESCs after treatment with 0, 0.5, and
2 Gy and exposed to p-(S1981) ATM antibody 15 min after radiation
(B) Immunostaining of 53BP1, p-(S1981) ATM, and γ-H2AX foci in
hESCs after single irradiation doses from 0.1 to 5 Gy. Cells were
fixed 15 min after radiation and exposed to the indicated antibodies.
Error bars, SEM for data sets n=30 cells per time point.
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Figure 3-2. γ-H2AX is consistent throughout the cell cycle.
Cycling hESCs were treated with 0, 2, 5, and10 Gy and fixed 15 min
after irradiation. Staining was determined by FACS analysis.
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hESCs lack a G1 checkpoint

Changes in cell cycle checkpoints as hESCs differentiate to NPs were determined
by PI staining (Table 3-1). hESCs had a much stronger G2/M checkpoint as compared to
NPs shown by the proportionally greater amount of cells in the G2/M phase. Here hESCs
had a peak of 39% of the cells in G2/M at 6 hr after IR compared to 14% at 18-30% for
NPs. hESCs did not display a G1 checkpoint because there was no increase in the
percentage of cell in the G1 phase of the cell cycle after 2 Gy. NPs, on the other hand,
increased the number of cells in G1 phase from 58% to 80% at 6 hrs and therefore display
a G1 cell cycle checkpoint.

Other have similarly shown that ESCs lack a G1 cell cycle

checkpoint and in mESCs it is possible to induce a checkpoint by over expression of
CHK2 (Koledova et al.; Aladjem et al. 1998; Hong and Stambrook 2004; Fluckiger et al.
2006).

hESCs have delayed γ-H2AX repair kinetics

The populations of hESCs, NPs, and fully differentiated astrocytes were used to
examine differences in radiation repair kinetics by following the appearance and resolution
of γ-H2AX (Figure 3-3). hESCs showed a significantly greater number of γ-H2AX foci 15
min after irradiation. The mean focus size in the hESCs was smaller than that in the NPs or
astrocytes which correlates with a large proportion of cells in S-phase (data not shown)
(Suzuki et al. 2006). The NPs and astrocytes shared similar profiles regarding the
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DNA Content, %
Cells Time Gy

G1

S

G2/M

hESC

0 hr
5 min
6 hr
18 hr
30 hr
30 hr

0
2
2
2
2
0

56
56
39
50
50
58

21
21
22
15
22
20

22
21
39
35
25
20

NP

0 hr
5 min
6 hr
18 hr
30 hr
30 hr

0
2
2
2
2
0

58
72
80
75
75
83

16
15
19
12
10
12

8
9
3
13
14
4

Table 3-1. Cell cycle checkpoint status. hESCs and NPs were
treated with or without 5 Gy and fixed at the indicated time point.
Cells were stained with PI and analyzed by FACS analysis.
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resolution of γ-H2AX. hESCs has a significantly higher number of IRIF remaining over
the 24 h time course. Altogether, hESCs and their more differentiated counterparts show
full competence, and differences, in the formation and resolution of γ-H2AX that might
reflect differences in the quality of DSB repair and cell cycle signaling.

RAD51 foci formation decreases with differentiation

HRR represents a high-fidelity mechanism of DSB repair. It is believed that the cell
must be in the S or G2 phase of the cell cycle in order for homologous sister chromatids to
act as a template for the damaged DNA (Valerie and Povirk 2003). The ability of the cells
to undergo HRR is uniquely dependent on RAD51, which is involved in
the search for DNA homology and strand pairing stages of repair (Valerie and Povirk
2003). Thus, we examined the formation and resolution of RAD51 foci after radiation
(Figure 3-4A). hESCs and NPs showed significant increases of cells with RAD51 foci
seen as early as 30 min after IR. Peak levels of cells with RAD51 foci (>75%) occurred
after 6 h in hESCs whereas NPs peaked at 12 h (Figure 3-4A). Conversely, astrocytes
showed very few cells with RAD51 foci (<3%) up to 24 h after radiation suggesting that
these cells completely lack HRR. The differences observed between the hESCs, NPs and
astrocytes are likely due to differences in proliferative rates. hESCs have a larger
proportion of cells in S-phase than do the NPs, whereas the astrocytes are no longer
proliferating and would thus have no S-phase. The small fraction of cells with RAD51 foci
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Figure 3-3. Characterization of DSB repair kinetics through
differentiation. hESCs, NPs and astrocytes were seeded in
chambered cover slips and 16 h after seeding exposed to 2 Gy. At
the indicated times cells were fixed and exposed to anti-γ-H2AX
antibody. Data are expressed as mean foci per cell on counting 100
cells per time point. Error bars indicate SEM. Data points, foci per
nucleus; Error bars, SEM for data sets n = 100. *p < 0.05: **p < 0.01;
***p < 0.001
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in the astrocyte population probably represents residual NPs or astrocyte progenitors we
also noted when cell proliferation markers were examined (Figure 2-3).

To determine whether the level of cells having RAD51 foci correlated with RAD51
expression we carried out a western blot of extracts from hESCs, NPs, and astrocytes using
anti-RAD51 antibody (Figure 3-4B). These cell populations were grown on dishes with
decellularized MEFs to avoid any protein contamination from the MEFs. The predicted
molecular mass of human RAD51 is 37-kDa. We found that the 37-kDa RAD51 form
diminished as the hESCs differentiated into NPs and astrocytes (1, 0.5, and 0.1-fold,
respectively) correlating well with the RAD51 foci results in Figure 3-4A. In addition, the
western blot analysis revealed that RAD51 might exist in different forms in the three
populations. A larger band at 41 kDa than the monomeric 37-kDa form appeared in the
extract from hESCs, and a band of smaller mass at 31 kDa was evident in the extract from
the astrocytes. Combined, these data show the reliance of hESCs and NPs on HRR while
terminally differentiated astrocytes lack functional RAD51 and HRR.
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Figure 3-4. Differentiation affects RAD51 foci formation and
expression. (A) Graphical depiction of the percentage of RAD51 foci
in hESCs, NPs, and astrocytes after 2 Gy. Cells were scored either
as positive (>1 focus) or negative (≤1 foci) for RAD51. Errors bars,
SEM for three independent data sets with n > 200. There were
statistically significant (p < 0.05) increases in the number of cells with
RAD51 foci after radiation compared to unirradiated cells at all time
points for hESCs and NPs whereas there was no statistical change in
the astrocytes. (B) Western blot showing expression of RAD51 in
hESC, NPs and astrocytes. Fold depicts relative differences in
RAD51 levels of the 37-kDa form after normalization to β-actin which
served as a loading control.
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Discussion

Here we have established conditions that allow for a low background of IRIF and
demonstrated a linear response for detection of the DSBs in hESCs form 0 to 2 Gy. Initial
formation of γ-H2AX foci at early time points varied for the different cell stages. hESCs
formed a greater number of foci compared to NPs and astrocytes at 15 minutes. When the
quantitative and qualitative aspects of cycling normal human fibroblasts were analyzed it
was found that S phase cells had a greater number of foci that were of smaller mean size
shortly after radiation (Suzuki et al. 2006). The greater number of foci found in S-phase
may be due to collapse of the replication machinery at sites of single-strand breaks. This
parallels the fact that hESCs are cycling very rapidly. hESCs also retained a larger number
of foci at later time points which may be due to several factors. One possible reason for the
delay in resolution could be greater reliance on HRR which is considerably more complex
and slower process than NHEJ. Another possibility may be more robust cell cycle
checkpoints in the hESCs. It has been shown resolution of γ-H2AX foci may not only be
related to the resolution of the DSB, but be necessary for exit from the DNA damage
checkpoint (Keogh et al. 2006). Current understanding of hESCs is that they have a
reduced G1 phase and may lack the G1/S DNA damage checkpoint entirely (Becker et al.
2006). In glioma cells it was found that those cells lacking p53 and hence the G1
checkpoint response had delayed resolution of γ-H2AX at later time points, which parallels
this data (Short et al. 2007). This delayed resolution of γ-H2AX is because the phosphate is
removed by specific phosphatases regulated by the cell cycle. One report shows when cell
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cycle checkpoints are over and these phosphatases are activated in order for the cells to
begin the cell cycle again (Chowdhury et al. 2005).

Our data are consistent with previous reports suggesting that hESCs have a robust
and active G2/M checkpoint and an absent G1 checkpoint, which first appears in the NPs
(Hong and Stambrook 2004; Becker et al. 2006; Fluckiger et al. 2006). Absence of G1
may be important because it possibly protects the genome of the ESCs. It may maintain a
pristine cell population by allowing for increased chance of apoptosis in cells with any
slight damage. Also the S/G2 phases of the cell cycle may up regulate expression of
factors involved in high fidelity repair.

The increase in the number of γ-H2AX foci in the hESCs at later time points after
radiation may also be due to increased radiosensitivity and cells undergoing apoptosis.
Apoptosis and DNA fragmentation leads to formation of γ-H2AX foci however this
activation is global throughout the nucleus and omitted by the cell profiler software
making it easy to distinguish between apoptosis and residual or potentially repairable
DSBs at later time points (Rogakou et al. 2000). It is important to examine γ-H2AX
staining across the cell cycle since genetic manipulation of the DNA repair enzymes or
pharmacological inhibition alters the cell cycle checkpoints. Initial experiments (Figure 32) demonstrate that even with perturbations of the cell cycle γ-H2AX would accurately
measure DSB repair signaling.
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Our results support the idea that, as expected but not yet unequivocally
demonstrated and reported in the literature, HRR is highly active in hESCs and declines as
cells differentiate into NPs and disappears entirely in astrocytes. We document that both
hESCs and NPs rely heavily on HRR by the presence of RAD51 foci formation. hESCs
display a higher percentage of cells with RAD51 foci at earlier time points then the NPs
indicating more robust HRR in hESCs than in NPs. The data here demonstrates that cells
early in development rely to a large extent on HRR and/or high-fidelity DSB repair.

On the other hand, after terminal differentiation of hESCs into astrocytes HRR is
no longer utilized. In conjunction with this result, we found that RAD51 decreases in
expression from the embryonic to the NP state. Furthermore, this protein seems to undergo
extensive post-translational processing after terminal differentiation to astrocytes. One
report showed that cleavage of RAD51 occurred in cells undergoing DNA fragmentation
and apoptosis (Flygare et al. 1998; Huang et al. 1999). This post-translational processing
might represent another layer of control for the cell to determine which form of DSB repair
to utilize. Investigation of what controls these repair mechanisms must be evaluated
further in order to conclude how cells maintain the genetic code.
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Chapter 4 ATM and ATR’s Role in DSB Repair Signaling through
Differentiation

Introduction

Chapter 3 describes multiple differences in repair mechanisms that were observed
for embryonic and differentiated cells including the kinetics of repair and types of repair
utilized as well as changes in the cell cycle. Earlier it was noted that the G1/S checkpoint
is absent in hESCs. A main contributor to the G1/S checkpoint is ATM which may be
uniquely controlled in these cells. One study has shown that a possible reason for this is
that CHK2 is retained at the centrosome after IR exposure in mESCs throughout the cell
cycle. In somatic cells, CHK2 is predominantly diffuse within the nucleus and able to
phosphorylate some of its substrates, including p53, leading to G1/S arrest. Here, a G1/S
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arrest can be restored by ectopic expression of CHK2 and the restoration of a G1/S arrest
protects cells from apoptosis (Hong and Stambrook 2004). Conflicting reports on the
localization of p53 have been described in mESCs as well. One report indicated that DNA
damage does not activate p53 and these cells undergo p53 independent apoptosis (Chen
and Wang 1982). However, others have shown DNA damage in mESCs and hESCs can
induce differentiation (Lin et al. 2005; Qin et al. 2007). Further exploration as to what
controls the DDR can be achieved by inhibiting main components of the signaling
pathway.

Due to the radiosensitivity of A-T cells and DNA-PK deficient cells there has been
great effort to develop specific inhibitors against these enzymes due to their potential as
oncologic therapeutics. KuDOS Pharmaceuticals has developed KU-55933 (ATMi) and
KU-57788 (DNA-PKi) against ATM and DNA-PKcs kinases, respectively (Hickson et al.
2004; Hardcastle et al. 2005). Both ATMi and DNA-PKi are small-molecule inhibitors
that compete at the ATP binding site on their respective kinases. Our laboratory has
previously shown that ATMi blocks homologous recombination repair in cycling and
arrested glioma cancer cells (Golding et al. 2007).

Another mechanism to perturb the DNA damage pathways is to use the
radiosensitizing agent caffeine. Caffeine has been shown to inhibit both ATM and ATR,
showing a greater specificity for ATM than ATR (Sarkaria et al. 1999). Therefore
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increasing concentration of caffeine should eventually inhibit two of the main signaling
kinases in this pathway and could provide insight into the components of DSB repair.

Small interfering RNAs represent another method to achieve a decrease in
expression of genes. This evolutionary conserved mechanism that provides for viral
defense and control of development allows for down regulation of proteins or mRNA
degradation when there is a ≈21-25 nucleotide double stranded RNA with an antisense
strand complimentary to a particular gene. When double stranded RNA (dsRNA) from a
virus or laboratory manipulations is present in the nucleus it will be loaded into the RNA
induced silencing complex. Within this complex there is an aptly named RNase enzyme,
DICER, which cleaves the mRNA that the antisense RNAi strand pairs with endogenously,
thereby eliminating the mRNA needed to translate the gene of interest.

Materials and Methods

Antibodies and reagents

Primary antibodies used for staining were anti-γ-H2AX (S139) (Millipore, MA),
anti-p-(T68)-CHK2 (Cell Signaling, Beverly, MA), anti-RAD51 (EMD Biosciences), anti53BP1 (BD Transduction Laboratories), anti-β-actin (Santa Cruz Biotechnology). Drugs
were dissolved in DMSO. Caffeine from Sigma/Aldrich (St Louis, MO) was dissolved in
water.
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Downregulation of target genes

Expression of ATR was downregulated using siRNA from Dharamacon, Int.
(Lafeyette, CO). siRNAs were transfected 24 h after seeding of hESCs at a concentration
of 80 nM using Dharamafect 1, according to the manufacturer’s instructions. Efficiency of
knockdown was analyzed by quantitative polymerase chain reaction (qPCR) and western
blot. Downregulation was also performed through Amaxa nuclefection (Lonza) according
to manufacturer’s instructions. For ATR knockdown Dharmacon Products L003202-000005

with

sequences

GCAACUCGCCUAACAGAUA

5’
3’,

GAGAAAGGAUUGUAGACUA
5’

CCACGAAUGUUAACUCUAU

3’,
3’,

5’
5’

CCGCUAAUCUUCUAACAUU 3’ were used and for GFP knockdown Dharmacon
generated 5’ GAACGGCAUCAAGGUGAACdTdT3’ oligo was used.

mRNA analysis

Genomic DNA was extracted using the High-Pure PCR Template Preparation Kit
(Roche). Amplification of genomic DNA was performed on an ABI 7900HT Real-time
qPCR instrument using Taqman Gene Expression Master Mix (Applied Biosystems).
Relative ATR levels were determined after normalizing to GAPDH. The PCR primers used
for ATR were HS00169878_m1 and for GAPDH were HS99999905_m1 (Applied
Biosystems).
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Results

ATM is dispensable for the formation and resolution of DSBs in hESCs but
indispensable in astrocytes.

ATM regulates the DNA damage response after IR (Valerie and Povirk 2003).
ATM has previously been shown to be critical for both HRR and NHEJ (Riballo et al.
2004; Wang et al. 2004; Golding et al. 2007). To determine whether ATM plays a role in
the resolution of IRIF in these cells, we took advantage of a highly specific inhibitor, KU55933, of the ATM kinase (Golding et al. 2007). The ability of hESCs, NPs, and astrocytes
to form and resolve DSBs was assessed by treating cells with ATMi (Hickson et al. 2004).
After treatment of hESCs with ATMi, there was no statistical difference in the resolution
of γ-H2AX foci between untreated and ATMi treated cells indicating that ATM is
dispensable for DSB repair in hESCs (Figure 4-1A). On the other hand, both NPs and
astrocytes reacted as expected based on our previous results with human glioma cells
(Golding et al. 2007), i.e., the γ-H2AX foci did not form at all in sharp contrast to the result
with the hESCs (Figure 4-1A).

To determine whether ATMi inhibited foci formation or promoted the disassembly
of IRIF, we allowed foci to form and 15 min after radiation ATMi was added to the
medium (Figure 4-1B). We found that not only did foci formation not occur in astrocytes
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Figure 4-1. ATM kinase is important for γ-H2AX foci resolution in
astrocytes but not in hESCs. Graphical depiction (left panel) and
images (right panel) of γ-H2AX foci in hESCs, NPs, and astrocytes
exposed to 10 μM ATMi (A) 1 h prior to or (B) 15 min after radiation
with 2 Gy. Asterisks indicate statistical significance between the data
sets generated with NPs and astrocytes, respectively, with ATMi
present or not at the same time point. Data points, foci per nucleus;
Error bars, SEM for data sets n = 50.
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6h

treated with ATMi but the drug even promoted the disassembly of already formed IRIF.
Over time, the sharp IRIF seen at earlier time points (<3 hrs) became more diffuse and
completely dissolved over time. Thus, the apparent disappearance of γ-H2AX IRIF to
levels lower than those seen without ATMi is likely due to the disassembly of foci and not
more proficient repair as suggested by the steeper slope of the curve for ATMi-treated
astrocytes (Figure 4-1B). The finding that there was no effect of the ATMi on DSB repair
in BG01V cells was confirmed with the H9 human embryonic stem cells suggesting that
this finding was not just an anomaly associated with the BG01V cells (Figure 4-2).

Possible explanations for the lack of an effect of ATMi on the resolution of
radiation-induced γ-H2AX foci in hESCs include that these cells were refractory to the
drug (poor uptake, more effective drug break-down, etc) or, alternatively, they do not
depend on ATM for DSB repair. To distinguish between these two possibilities, we
examined the effect of ATMi on preventing the phosphorylation of CHK2 at T68 in
irradiated hESCs. CHK2 phosphorylation at this position is believed to be ATM-dependent
(Hickson et al. 2004; Golding et al. 2009a). Surprisingly, we found that when ATMi was
used at a dose that blocks radiation-induced phosphorylation of p53 (S15), H2AX (S139),
and CHK2 (T68) in an ATM-dependent manner in human tumor cell lines (Golding et al.
2009b), it did in fact inhibit CHK2 phosphorylation >85% in irradiated hESCs (Figure 43). Similarly, γ-H2AX levels were reduced ~50% when cells were exposed to ATMi.
Therefore, the lack of an effect of ATMi in hESCs by IRIF assay is not because the drug
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Figure 4-2. DSB repair in H9 hESCs is unaffected by treatment
with ATMi and DNA-PKi. Graphical depiction of γ-H2AX foci in
hESCs, NPs, and astrocytes exposed to 10 μM ATMi or 2.5 μM DNAPKi 1 h prior irradiation with 2 Gy. Data points, foci per nucleus; Error
bars, SEM for data sets n = 50.
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Figure 4-3. ATM kinase is functioning in hESCs. Extracts from
hESCs 15 min after exposure to 5 Gy with or without ATMi (10 µM)
added 1 h prior to radiation. Fold change depicts phosphorylation of
CHK2 (T68) and H2AX (S139). β-actin served as loading control.
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does not work or that the ATM kinase is not available or inactive in these cells, but instead
because ATM is not critical for the formation and resolution of repair foci in hESCs.

Recent reports have indicated that the CHK2 pathway is compromised in mESCs
and this protein is retained at the centrosome, unable to translocate to the nucleus (Hong
and Stambrook 2004). This phenomenon was examined in hESCs to see if CHK2 was
sequestered in a similar manner as the mESCs. When examined if this were true in ESCs,
it was found that pCHK2-threonine 68 was located at the mitotic spindle in hESCs (Figure
4-4). This can be demonstrated by colocalization of CHK2 with γ-Tubulin, a protein
present in large quantities at the mitotic spindle.

Inhibiting ATR abrogates DSB repair in hESCs.

ATR is known to serve as backup for ATM, is critical for regulating the DDR
during replication, and is important for DSB repair (Cliby et al. 1998; Wang et al. 2004).
Caffeine inhibits both ATM and ATR, with a greater potency against ATM than ATR
(Sarkaria et al. 1999). Thus, caffeine was first used to examine the effects on γ-H2AX foci
formation after irradiation. At 2 mM, caffeine is expected to inhibit ATM but not ATR
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Figure 4-4. pCHK2 is localized to the centrosome. hESCs were
prepared for confocal microscopy and then incubated with pCHK2
(green) and γ-tubulin (red). Arrows show colocalization of proteins.
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(Golding et al. 2004). Indeed, at this concentration there was no effect on γ-H2AX foci
formation (Figure 4-5A), a result which is in agreement with the finding that ATMi does
not affect foci formation in these cells (Figure 4-1). However, after treatment with 4 and 8
mM, a 21% and 47% reduction in γ-H2AX foci, respectively, was observed at early times
after irradiation (Figure 4-5A, top panel). Similar levels of inhibition were seen at 1 h as
well.

Furthermore, RAD51 foci were almost completely absent (≤3 h) in cells treated
with 8 mM caffeine and reduced with 4 mM (Figure 4-5A, bottom panel). Later time
points (>3 h) showed significant cell death after treatment with 4 and 8 mM caffeine and
were therefore not pursued further. Combined these results suggest that ATR and not ATM
is critical for DSB repair in hESCs. Because hESCs depend on HRR to a large extent, it is
likely that ATR regulates HRR in hESCs as has been shown in fibroblasts (Wang et al.
2004).

To confirm the result with caffeine and more clearly establish a role for ATR in
DSB repair in hESCs, we transfected the cells with siRNA targeting ATR and examined
the impact on DSB repair. hESCs transfected with ATR siRNAs showed significant (4570%) knockdown of ATR expression, but no effect on DNA-PKcs levels (Figure 4-5B
and C). This knockdown led to a reduction of γ-H2AX foci by >70% in cells treated with
radiation (Figure 4-5D and E). Interestingly, unirradiated cells showed low levels of γ-
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H2AX foci, which increased almost 2-fold when ATR was knocked down. These results
suggest that ATR is critical for HRR in hESCs.
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Figure 4-5. ATR is required for DSB repair in hESCs. A.
Graphical depiction of γ-H2AX (top panel), and RAD51 (bottom panel)
foci determined in the presence of 0, 2, 4, and 8 mM caffeine
administered 1 h prior to radiation (2 Gy). Asterisks designate
statistical significance between the two data sets adjacent to the
asterisk at the same time point. Data points, foci per nucleus; Error
bars, SEM for data sets n = 50. B. Graphical depiction of ATR mRNA
levels normalized to GAPDH mRNA after transfection with GFP
control siRNAs and siRNAs targeting ATR. Experiments were
performed in triplicate, and the SEM indicated by error bars. C.
Western blot showing ATR expression 48 h after transfection of
BGO1V cells with GFP control siRNAs or siRNAs targeting ATR. The
fold change in ATR was calculated after normalization to DNA-PKcs
which served as a loading control. D. Graphical depiction of the
effects of ATR knockdown on DSB repair determined by γ-H2AX foci.
Cells were transfected with GFP control siRNAs or siRNAs targeting
ATR, irradiated with 2 Gy 48 h after transfection, and fixed 6 h later.
Data points, γ-H2AX foci per nucleus; Error bars, SEM for data sets n
= 100. E. Representative images of cells with γ-H2AX foci (red) with
DAPI staining showing nuclei (blue).
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Discussion

Experiments described in this chapter delineate changes in DSB repair through
differentiation. An unexpected finding herein was that ATMi blocked the formation of γH2AX and p-(S1981) ATM foci in NPs and astrocytes, but had no effect on the repair in
hESCs. ATMi functions in hESCs since radiation-induced CHK2 phosphorylation was
inhibited at an ATM-specific phosphorylation site. There was also a significant increase in
the γ-H2AX foci in the unirradiated cells with ATR knockdown. This result has been
shown before in ATR deficient mouse embryonic cells due to replicative stress induction
as a result of ATR not signaling for repair (Murga et al. 2009). Our data suggest that
astrocytes and NPs rely to a large extent on ATM for the formation and maintenance of
repair complexes, whereas hESCs (and NPs to a lesser extent) may have ATR acting as a
mediator to identify DSBs. ATR is an essential protein, whereas ATM is not, suggesting
that ATR has a vital role early in development as suggested by the inability to obtain ATR
knockout mice (Brown and Baltimore 2000). In conditional knockouts, ATR has been
shown to be critical for preservation of the stem cell compartment of adult tissues
(Ruzankina et al. 2007). ATR may be directly responsible for DSB signaling in hESCs,
and to some extent in NPs, similar to tumor cells. Previous reports established that ATM is
inhibited by caffeine more readily than ATR (Sarkaria et al. 1999; Golding et al. 2004).
We show that caffeine at higher doses of >4 mM inhibit IRIF formation. In support of this
finding, siRNA-mediated knock down of ATR and subsequent reduction in γ-H2AX foci
strongly supports the notion that ATR is absolutely critical for HRR in hESCs. We have
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also shown that CHK2 phosphorylation is lost in presence of ATMi and this protein may
be sequestered at the centrosome similar to what is found in mESCs. Therefore this
pathway is active in the early signaling events of the checkpoint and the ATM kinase
inhibitor is effective at decreasing its function on known substrates involved in the G1
checkpoint.

We conclude that the lack of an effect of ATMi in hESCs is not because the drug
does not work or that the ATM kinase is not available or active in these cells, but instead
because ATM is not critical for the formation and resolution of DSBs in hESCs. We show
that KU-55933 is effective in hESCs at lower concentrations typically used to block the
DDR in tumor cell lines since radiation-induced CHK2 and H2AX phosphorylation was
inhibited (Golding et al. 2009b). This consistent effect of KU-55933 on hESC would
thwart the notion of any significant effect of a drug pump (Momcilovic et al. 2009b). The
reason why we do not see any effect of KU-55933 on the formation of p-(S1981)-ATM
foci after radiation of hESCs is most likely because this antibody recognizes a number of
other DDR proteins phosphorylated by ATM and ATR, such as SMC1, in addition to autophosphorylated ATM (Matsuoka et al. 2007).

Recent publications have shown that checkpoint signaling in irradiated hESCs was
not affected by ATMi. Effects in this publication were seen only at levels 10 fold higher
than in other cell lines (Momcilovic et al. 2009a). Such high concentrations may indicate
that the drug is having off target effects. In parallel to the publication of these findings it
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was found that ATM was not involved in the maintenance of genetic stability in hESCs
when this gene was removed by targeted allele disruption (Song et al.). Importantly we
show ATR is responsible for the formation and resolution of DNA DSBs in hESCs and
likely HRR signaling.
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Chapter 5 NHEJ in hESCs

Introduction

Chapters 3 and 4 began to unravel unique properties of ESCs including their
reaction to DSBs. While hESCs seem to rely on HRR extensively, there is no clear
documentation that they utilize NHEJ. Since NHEJ dominates in G1 and hESCs have an
abrogated G1 checkpoint, NHEJ may be deficient in these cells. There are reasons
deficient NHEJ could be advantageous to maintain hESCs genomic stability. One reason
is that unrepaired damage that has occurred in G1 may lead to increased apoptotic
signaling, which has been shown to be upregulated in ESCs. This mechanism would clear
damaged cells from the gene pool. Deficient NHEJ would also increase the level of HRR
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since the factors of each mechanism are in competition at site of the DSB (Allen et al.
2002). This would increase genomic stability by allowing greater use of the mechanism
with the highest fidelity of repair. The details of this process are described earlier (Figure
1-4).

In NHEJ evidence shows small sequence gaps with microhomology are filled by
Pol µ and Pol λ (Lee et al. 2004; Nick McElhinny et al. 2005). Several factors determine
whether HRR or NHEJ is employed including stage of the cell cycle, growth factor
signaling, and the severity and type of damage (Valerie and Povirk 2003; Golding et al.
2009a). Recently, it has been shown that in S. cerevesiae the extent of DNA resection after
damage can influence the choice of which mechanism of DSB repair is utilized as well
(Huertas et al. 2008).

Materials and Methods

Antibodies and reagents

Primary antibodies used for staining were anti-DsRed, anti-β-actin, anti-Oct3/4
from Santa Cruz Biotechnology (Santa Cruz, CA), and anti-HA from Cell Signaling
(Beverly, MA).

NHEJ repair.
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BG01V/NHEJ-red cells were isolated by infection of BG01V cells with a lentivirus
(WPXLd-2xISceI-DsRed) harboring a repair cassette (hereafter referred to as the NHEJred) (Figure 5-1A) positioned upstream of the DsRed reporter gene that was recently
described with the exception that an IRES-NEO selection cassette was added (Figure 51A) (see Supplemental Methods in (Golding et al. 2009a)). Cells resistant to G418 were
cloned by dilution and screened for the integration of NHEJ-red by infection with
adenovirus expressing the I-SceI endonuclease from Saccharomyces cerevisiae (Ad-SceI)
(Golding et al. 2009a), followed by subsequent analysis of DsRed expression. Cells were
infected with adenovirus with a multiplicity of infection (MOI) of 30 while dishes were
rocking at 37oC for 4 h.

The NHEJ-red assay has been described previously (Golding et al. 2009a), and
relies on a cassette containing two I-SceI recognition sequences flanking an ATG codon
that when not cut by I-SceI, acts as a decoy initiation codon, preventing translation of the
DsRed reporter gene. Upon cleavage with I-SceI at both recognition sequences, the decoy
codon is excised within a 25-base sequence stuffer fragment. If NHEJ DNA repair occurs,
the DNA is sealed, and DsRed expressed from a downstream, previously out of frame
ATG codon (see Figure 5-1A). The two I-SceI recognition sites are in opposite
orientations, such that when both are cleaved with I-SceI and the stuffer fragement of the
vector is excised, two partially complementary 5′ overhangs are generated: TTAT and
TATT. If the generated partially complementary ends anneal without DNA-end resection,
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a two-base gap will result on both strands which would be filled in, likely by a gap-filling
polymerase. This possible repair scenario would result in a repair joint sequence reading
TTATAA, which we define as high-fidelity NHEJ (“HiFi” NHEJ). More extensive
resection would still result in DsRed expression unless the deletion is so extensive that it
removes the downstream DsRed ATG codon or removes the upstream promoter. NHEJ
events are then determined by FACS of DsRed positive cells and/or genomic qPCR, or by
cloning and DNA sequencing.

DsRed 2x-SceI-NHEJ cassette Cell Cloning

After infection with DsRed cassette, hESCs were selected for integration of the
virus 48 hrs after infection. Cells were selected for integration of the cassette with
100µg/mL of G418. After one week cells were trypsinized and plated in 24 well plates
containing decellularized matrix. Single colonies were then picked after cells had grown
up and these cells were tested for formation of the 125 base pair product amplicon relative
to β-actin. Several positive clones were then grown up and a clone designated 4 was used
for experimentation.

Genomic DNA was extracted using the High Pure PCR Template Preparation Kit
(Roche). Amplification of genomic DNA was performed on an ABI 7900HT Real-time
qPCR instrument using SYBR Green (ABI, Foster City, CA). Relative NHEJ levels were
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determined after normalizing to β-actin levels. The PCR primers used for the NHEJ
quanitifcation were 5′-CACGAGACTAGCCTCGAGGTTT, 3′CTTGAAGCGCATGAACTCCTT, and for β-actin were 5′TCACCCACACTGTGCCCATCTACGA, and
3′-CAGCGGAACCGCTCATTGCCAATGG (synthesized by the VCU Massey Cancer
Center Nucleic Acids Research Facility). Analysis was performed with the ABI Relative
Quantification Assay with the cycling conditions as follows; Cycle 1 for 1 cycle at 95oC
for 10 min, Cycle 2 for 40 cycles of 95oC for 15 sec followed by 60oC for 1 min. Relative
DNA levels of the NHEJ repair product and β-actin with Sequence Detection Systems
software.

In addition to quantitative SYBR Green PCR, bands were also separated on a 9%
non-denaturing polyacrylamide gel, detected by ethidium bromide staining, and imaged on
a Typhoon 9410 variable mode scanner (General Electric Healthcare).

DsRed Analysis

DsRed fluorescence was detected with flow cytomtery, performed on live cells. Briefly,
cells were trypsinized and taken up in DMEM/10% FBS. Gating functions were applied to
a 2-D plot of side scatter versus forward scatter so the live cell population could be
analyzed. DsRed+ cells were quantified by gating a 2D plot of green fluorescence versus
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red fluorescence. Cells were analyzed on a Coulter Epics XL MCL flow cytometer at the
Massey Cancer Center Flow Cytometer Facility.

Results

hESCs utilize NHEJ for DSB repair.

Previous work has shown that hESCs are highly proliferative cells with strong G2
checkpoints and an absent G1 checkpoint (Momcilovic et al. 2009a). For this reason it is
believed hESCs would depend extensively on HRR. Indeed, we recently showed that
hESCs form RAD51 foci, a marker for HRR, far more extensively and express RAD51 at
10-fold higher levels than differentiated astrocytes (Adams et al.). We also demonstrated
that the relatively fast repair kinetics using γ-H2AX as surrogate marker suggested that
hESCs have NHEJ (Adams et al.). However, both γ-H2AX and 53BP1 foci resolution was
relatively unresponsive to a small molecule inhibitor of DNA-PKcs kinase suggesting that
NHEJ in hESCs is largely independent of DNA-PKcs (Adams et al.). To determine the
nature of NHEJ in hESCs, and to clarify the role of DNA-PKcs in NHEJ these cells, we
engineered the hESCs with a lentivirus carrying a repair cassette that would make them
more amendable for repair analysis.

BG01V cells were infected with the NHEJ-red lentivirus (LV) (Figure 5-1A)
followed by cell cloning and expansion in G418 supplemented media. A number of
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clones were isolated and one was chosen for further study. The hESC clone was infected
with the I-SceI expressing adenovirus and shown to be positive for Oct3/4 nuclear staining,
indicating that they are hESCs and positive for DsRed after infection with Ad-SceI.
Therefore, the hESCs appear to utilize NHEJ since the production of DsRed after I-SceI
adenoviral infection could only occur by repair with NHEJ (Figure 5-1B).

Repair of NHEJ-DsRed cassette detected by novel qPCR assay

After validation of the fluorescence-based NHEJ assay via immunocytochemistry,
the NHEJ cassette integrated in to the genome was used as the basis for a more rapid qPCR
assay. Determining the levels of NHEJ in this assay relies on the 2X-SceI-NHEJ vector,
primer design, and qPCR conditions. The vector is cleaved by SceI at two sites and
resealed with loss of a 25 bp fragment. Primers amplify the DNA with greater efficiency
than the uncut vector starting material. Determining DNA break resealing via qPCR is a
more direct, quantitative method that eliminates transcriptional or translational effects that
may compromise fluorescent protein based DNA repair assays (18). Figure 5-2A shows a
time course for the increase of the 125 bp band produced by NHEJ. The PCR band is
shown by gel electrophoresis to be the size of the product after loss of the small DNA
fragment and repair by NHEJ (Figure 5-2B). The relative change in fluorescence detected
in the infected samples while using the same PCR primer set shows the 125 base product is
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Figure 5-1. NHEJ-red repair cassette and processing of I-SceI
cut. (A) Schematic of the NHEJ-red cassette. (B) Oct3/4 (green)
positive hESCs display DsRed (red) positive cells 48 hrs after
infection with 30 multiplicity of infection (MOI) of Ad-SceI adenovirus.
DAPI shows nuclear staining.
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NHEJ repair product at ~125 base pair fragment at indicated times.
(C) Relative NHEJ levels after infection with Ad-SceI adenovirus with
30 MOI at 24 hrs.
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detected at levels 139-fold higher than the same uninfected clone (Figure 5-2C).

NHEJ repair kinetics through differentiation

It is possible that a change in adenovirus expression may occur through
differentiation which would alter the reliability of the repair assay. Figure 5-3A shows
that when the hESCs, NPs, and astrocytes are infected with an equal amount of adenovirus
containing HA-tagged I-SceI there is an identical amount of HA protein expressed at 24 h.
Since the enzyme is cutting at identical rates we are able to show the quantity of NHEJ
repair increases through differentiation. Figure 5-3B shows that astrocytes have 2.3 fold
greater amount of DNA repaired compared to hESCs. As cells transition from hESCs to
NPs there is a trend of increase in the DNA repaired by NHEJ, however this difference is
not significant. This data is supported by flow cytometry analysis analyzing the quantity
of DsRed. Here again we showed an increase in DsRed, representing NHEJ repair, as cells
differentiate. Due to the time needed for translation of the DsRed protein 48 and 72 h time
points were utilized. This assay shows quantitatively the DsRed is produced faster in
astrocytes and once again there is no difference between hESCs and NPs. At 48 h the
astrocytes had 2.6 fold more cells expressing DsRed than hESCs (Figure 5-3C). Also at 72
h there is a 1.6 fold increase in DsRed in astrocytes (Figure 5-3C and D). Once again
there was no significant difference between the hESCs and the NPs.
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were seeded and 12 h later infected Ad-SceI at an MOI of 30.
Samples were harvested 24 h after infection. (B) BG01V, NP, and
astrocyte/NHEJ-red cells were infected with Ad-SceI and collected at
24 h post-infection. (Columns) Relative NHEJ levels were normalized
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Discussion

The IRIF foci assay utilizes surrogate markers for repair to determine differences in
ESCs and differentiated progeny, however further proof with a repair cassette is needed to
further substantiate previous findings. Herein we employed the use of a modified cassette
that can not only define the quantity of DNA repaired by NHEJ, but also the fidelity with
which the DSB was repaired. There is a requirement for high fidelity DNA repair of DSBs
in ESCs since they give rise to all the cells of the organism. Knockout studies demonstrate
ESCs utilize HRR compared to NHEJ as a principal mechanism of repair (Orii et al. 2006).
These cells are proficient in HRR as indicated by the extensive formation of RAD51 foci
after irradiation. Current understanding is that there is correlative evidence that NHEJ may
exist in hESC but no direct linkage has been shown (Biton et al. 2007; Banuelos et al.
2008). There is strong evidence however that in mESCs DNA-PKcs is not expressed and
NHEJ is defective in these cells (Banuelos et al. 2008). Here we show that Oct3/4+
embryonic stem cells in fact utilize NHEJ as a method for DSB repair.

Also using this NHEJ cassette we were able to demonstrate slower repair kinetics
in the proliferating hESCs and NPs as compared to the terminally differentiated astrocytes.
This was shown not only through the PCR assay but also examining DsRed positive cells
at later times to allow for translation of the protein. Current understanding of the D-NHEJ
is that it is defined by faster repair kinetics compared to alternative forms of NHEJ repair.
The B-NHEJ also seems to occur in the G2 phase of the cell cycle more readily (Wu et al.
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2008). It has been shown that cells lacking components of the D-NHEJ perform end
joining with the preferential use of microhomologies (Kabotyanski et al. 1998). This data
may indicate the fact that rapidly cycling hESCs may show a preference for B-NHEJ or
microhomology mediated NHEJ compared to differentiated astrocytes.
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Chapter 6 High Fidelity Repair in hESCs

Introduction
Chapter 3 showed that a current small molecule inhibitor targeted against ATM is
ineffective at altering the recognition or resolution of the DSB in hESCs. These assays
follow surrogate markers of repair and are not probing the actual DNA break site. Using
the described NHEJ assay it is possible to scrutinize whether the cutting of DNA by a
restriction enzyme can be altered by the drugs. It was shown in Chapter 4 that the cycling
hESCs and NPs have slower repair kinetics.

Interestingly a backup NHEJ pathway utilizing poly (ADP-ribose) polymerase1(PARP-1), Histone H1 and Ligase III/XRCC1 has begun to be described (Audebert et al.
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2004; Wang et al. 2006). This new pathway has been studied in fibroblasts and cancer
cells, but not in hESCs (Bennardo et al. 2008; Iliakis 2009). Current studies in a chicken
B cell line show that knockout of D-NHEJ factors slows repair kinetics, but equal amounts
of repair can occur. Interestingly, additional knockout of HRR factors as well as D-NHEJ
factors produced the same effect as knocking out D-NHEJ factors alone so this form of
repair is independent of HRR (Wang et al. 2001).

It has also been shown that there is a cell cycle dependence on whether DNA-PK
dependent or alternative forms of NHEJ are used. When the three dominant NHEJ factors,
DNA-PKcs, Lig4, and Ku70, are knocked out there is a defect in repair in cells in the G1
phase but not in the G2 phase (Wu et al. 2008). These data indicate a cell cycle regulation
of the backup NHEJ similar to HRR. Inherent to all of these studies is the use of cancer
cells or immortalized cells that are not indicative of true physiologic signaling. The
current system utilized begins to clarify when B-NHEJ may predominate.

Currently there is contrasting evidence as to which factors may control the fidelity
of NHEJ. Some studies suggest that the D-NHEJ prevents loss of genetic information
(Difilippantonio et al. 2000; Gao et al. 2000), while others show that microhomology
mediated repair may occur to an equal or greater extent when these factors are absent
(Kabotyanski et al. 1998; Perrault et al. 2004). The differentiation assay preformed here
can show whether cell cycle, differentiation, or epigenetic effects collectively alter the
usage of this microhomology directed NHEJ repair.
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Materials and Methods

Antibodies and reagents
Primary antibody used for staining were anti-γ-H2AX (S139) (Millipore, MA).
KU-59436 (PARPi) was dissolved in DMSO.

Downregulation of DNA-PKcs
DNA-PKcs and ATR expression was knocked down using the Smartpool M005030-01-05 and the SmartPool M-003202-05, respectively. A GFP siRNA (5’GAACGGCAUCAAGGUGAACdTdT-3’) was used as a control. All siRNAs were
purchased from Dharmacon. hESCs were nucleofected using program A-023 (Lonza
Nucleofector II) and Nucleofector Embryonic Stem Cell Kit II solution and 200 nM
siRNAs according to the manufacturer’s recommendations as described previously (Adams
et al.).

“HiFi” DsRed Repair Cassette Analysis
qPCR was used to determine the extent of NHEJ as described in Chapter 4. When
amplifying genomic samples to be digested with PsiI, Amplitaq Gold Master mix (ABI,
Foster City, CA) was used. The samples were then digested with 5 units of PsiI, in NEB
82

buffer 4, in 25 uL reactions. Digested bands were separated on a non-denaturing
polyacrylamide gel, and stained and imaged as previously described. Densitometric values
were quantified using QuantityOne analysis software (Bio-Rad).

PCR Product Cloning and Sequencing

Genomic DNA was extracted using the High Pure PCR Template Preparation Kit
(Roche). Amplification of genomic DNA was performed on an ABI 7900HT Real-time
PCR instrument using the Amplitaq Gold Master Mix (ABI, Foster City, CA). Relative
NHEJ levels were determined after normalizing to β-actin. The PCR primers used were the
same as described for the qPCR assay. DNA was cloned using the TOPO TA Cloning kit
(Invitrogen) as described by the manufacturer’s instructions. DNA sequencing was
performed by MCV-VCU Nucleic Acids Research Facility.

Results

Astrocytes rely to a large extent on NHEJ.
To further characterize DSB repair in the astrocytes, we examined a possible
dependence on DNA-PKcs in the repair of DSBs. Taking advantage of the highly specific
DNA-PKcs kinase inhibitor, KU-57788 (NU7441) (Hardcastle et al. 2005; Povirk et al.
2007; Golding et al. 2009b), we show that DNA-PKcs, in part, is important for the
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resolution of both γ-H2AX and 53BP1 foci in astrocytes (Figure 6-1A, top panel). At 6 h
after irradiation, >40% of γ-H2AX foci remained in the DNA-PKi-treated astrocytes
compared to only 21% in the untreated. Importantly, the DNA-PKi-treated cells had more
repair foci remaining throughout the entire time course, suggesting that DNA-PKcs is
important for repair but repair is not fully dependent on DNA-PKcs. This response is in
sharp contrast to that seen when cells were treated with ATMi where the slope of foci
disappearance was steeper, most likely reflecting the disassembly of repair complexes (see
Figure 4-1). Similarly, ~80% of 53BP1 foci remained in the DNA-PKi-treated cells
compared to only ~30% in the untreated cells when the drug was added after irradiation
(Figure 6-1A, bottom panel). These results further suggest that repair complexes remain
at the DSB but repair proceeds slower, reflecting a dependence (50-65%) on DNA-PKcs,
presumably as a critical component in NHEJ (Valerie and Povirk 2003). Importantly, when
both DNA-PKi and ATMi were combined, there was a complete lack of γ-H2AX foci
formation after irradiation, demonstrating an effect similar to ATMi alone (Figure 6-1A).

Whereas hESCs depend predominantly on HRR, as we have shown here, there was
no effect of DNA-PKi on the resolution of either γ-H2AX or 53BP1 IRIF in hESCs
(Figure 6-1B), a result which is in sharp contrast to that seen with the astrocytes. This
result with DNA-PKi was also recapitulated with the H9 hESC line (Figure 4-2) and
suggests that DNA-PKcs is not important for DSB repair in hESCs.
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Figure 6-1. Astrocytes rely completely on NHEJ. (A) Graphical
depiction of γ-H2AX (top panel) and 53BP1 (bottom panel) foci in
astrocytes after radiation. Cells were treated or not with ATMi (10
µM), DNA-PKi (2.5 µM) or both for 1 h followed by irradiation with 2
Gy. Asterisks designate statistical significance between data sets of
untreated and drug-treated cells at the same time point. (B) Graphical
depiction of γ-H2AX (top panel) and 53BP1 (bottom panel) foci in
hESCs treated or not with DNA-PKi (2.5 µM) followed by radiation
with 2 Gy. Data points, foci per nucleus; Error bars, SEM for data sets
n = 50.
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ATM and DNA-PKcs kinases are not critical for NHEJ in hESCs.
It was previously shown that the ATMi, is only partially effective at abrogating
DSB repair even though checkpoint signaling in hESCs was blocked (Adams et al.;
Momcilovic et al. 2009b). In order to verify that ATMi and DNA-PKi small molecule
inhibitors were entering the cells, analysis of p-KAP1 and γ-H2AX were analyzed. KAP1
is involved in chromatin remodeling after DNA damage and its activation is dependent on
ATM and DNA-PKcs at early time points (Tomimatsu et al. 2009). Furthermore, we
showed recently that H2AX phosphorylation is completely blocked after irradiation at
early times (≤15min) when both drugs are applied to glioma cells (Golding et al. 2009b).
Here, we show that KAP1 and γ-H2AX are reduced to near basal levels after 6 Gy when
treated with a combination of ATMi and DNA-PKi (Figure 6-2A).
Since these drugs alter DDR signaling in the hESCs we analyzed the effect on
NHEJ-red assay and show, in line with previous results, that both ATMi and DNA-PKi
were relatively ineffective at inhibiting NHEJ repair in hESCs (Figure 6-2B) (Adams et
al.). However, there was significant inhibition of 40-50% on NHEJ repair in the presence
of the two drugs in NPs (Figure 6-2C). This inhibition becomes even more pronounced
when these cells were further differentiated into astrocytes. Here, NHEJ was reduced to
25% when treated with ATMi and 27% when treated with DNA-PKi (Figure 6-2D).
Altogether, these results suggest that NHEJ in hESCs is not dependent on either ATM or
DNA-PKcs.
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Figure 6-2. Specific DNA-PKcs and ATM kinase inhibitors
become more effective as cells differentiate. (A) hESCs were
harvested 5, 10, and 15 min after exposure to 6 Gy with or without
ATMi (10 µM) and DNA-PKi (2.5 µM) or both. Drugs were added 15
min prior to radiation. Fold change depicts phosphorylation of KAP1
(S824) and H2AX (S139) after normalization to Chk1 which served as
a loading control. (B) BG01V/NHEJ-red (C) NP/NHEJ-red and (D)
astrocyte/NHEJ-red cells were infected with Ad-SceI and then treated
with either ATMi at 10 μM or DNA-PKi at 2.5 μM, 1 h after infection.
Cells were collected at 24 hr post-infection. (Columns) Relative NHEJ
levels was normalized to β-actin; (Error bars) SEM for data sets n =
3. Fold (x) indicates changes in the relative repair levels when
compared to the hESC sample. Differences in the scale of the
separate cell populations (B-D) are due to variation in the uninfected
sample PCR amplification from 3 separate experiments. Statistical
significance is marked between datasets and the SceI expressing
cells with no drug treatment.
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DNA-PKcs knockdown only slightly inhibits NHEJ in hESCs

To further investigate the results with the DNA-PKi and to better understand DNAPKcs’ role in NHEJ in hESCs, we transfected the hESCs with siRNA targeting DNA-PKcs
and then examined the impact on NHEJ. hESCs transfected with DNA-PKcs siRNAs
showed significant (90%) knockdown of DNA-PKcs expression between 48 and 72 hrs
(Figure 6-3A). It was also important to analyze the effect of the knockdown of DNA-PKcs
on adenoviral expression. Our lab has noted that changes in chromatin remodeling factor
expression such as KAP-1 alter adenoviral expression which can bias the repair assay and
fortunately, the 90% knockdown of DNA-PKcs did not affect the expression of SceI
(Figure 6- 3B). Despite the equal adenoviral expression there was a reduction in NHEJ
repair by 30-35% as determined by both flow cytometry and qPCR repair assay (Figure 63C and D). Therefore, in hESCs DNA-PKcs appears to play only a minor role in NHEJ.

High Fidelity NHEJ decreases as hESCs differentiate
If hESCs rely on alternative forms of repair it is possible there would be a
difference in the fidelity to which the repair occurs. As hESCs differentiated to NPs and
astrocytes there was a progressive decrease in the extent to which the overhangs were filled
in with AA nucleotides indicating “HiFi” NHEJ. hESCs displayed a 2.6-fold higher levels
of “HiFi” NHEJ compared to astrocytes, whereas NPs displayed a 1.8-fold increase
compared to astrocytes (Figure 6-4A and B). A U87 cell clone carrying the NHEJ-red
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Figure 6-3. DNA-PKcs knockdown partially reduces NHEJ in
hESCs. (A) DNA-PKcs expression 48 and 72 h after nucleofection of
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events collected; (Error bars) SEM for data sets n = 3. (D)
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vector (Golding et al. 2009a) showed a 1.3-fold higher level of “HiFi” NHEJ compared to
in vitro derived astrocytes (data not shown).

In order to verify the results that digestion with PsiI is indicative of “HiFi” NHEJ,
DNA sequencing of the PCR cloned products was performed. DNA sequencing revealed
that 50% of the amplified DNA contained the specific site for PsiI digestion (Table 6-1),
which correlates well with the ~55% value obtained previously (Figure 6-4A). Other
alterations found due to deletions or lack of fill-in of nucleotides by polymerases is shown
as well. Similarly, cloning and sequencing for the U87 clone was performed as well and
shown to correlate with the percent of “HiFi” repair from the PsiI and gel analysis (data
not shown). Altogether, “HiFi” repair appears to correlate with cell cycle and replicative
growth and was 2-3 fold higher in hESCs than in astrocytes and human glioma cells.

PARP-1 induces DSBs in hESCs but does not affect NHEJ
Our data suggest that rapidly dividing hESCs may rely extensively on a
microhomology-mediated form of NHEJ, therefore, inhibiting this pathway may reveal the
process responsible for NHEJ repair in hESCs. This may be accomplished using the
recently described PARP1/2 inhibitor, KU-54936 (PARPi), since PARP-1 has been
suggested to be involved in alternative forms of NHEJ (Wang et al. 2006; Menear et al.
2008). We show that the PARPi induces DSBs in hESCs and NPs leading to increased γH2AX foci formation (Figure 6-5A and B). Despite the efficacy of the drug there is no
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Table 6-1. Sequencing of NHEJ repair site.
DNA sequencing reveals the modifications to
the repair site after Ad-SceI infection. The
sequence obtained at the repair site, the
missing nucleotides, as well as the frequency
out of 28 clones is displayed.

Uncut Sequence
CCATTACCCTG TTATCCCTACTCGAGCCATGGCTAGGGATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCC
“HiFi”
TTTAAACTACGGGATCCATTACCCTGTTATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG
P1

TTTAAACTACGGGATCCATTACCCTG----ATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG

P2

TTTAAACTACGGGATCCATTACCCTGTTA------CAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG

P3

TTTAAACTACGGGATCCATTACCCTGTTATA--CAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG

P4

TTTAAACTACGGGATCCATTACCCTG----ATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG

P5

TTTAAACTACGGGATCCATTACCCTG----ATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG

P6

TTTAAACTACGGGATCCATTACCCTGTTATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG

P7

TTTAAACTACGGGATCCATTACCCTGTTATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG

P8

TTTAAACTACGGGATCCATTACCCTGTTATA--CAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG

P9

TTTAAACTACGGGATCCATTACCCTG--TATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG

P10 TTTAAACTACGGGATCCATTACCCTGTTATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG
P11 TTTAAACTACGGGATCCATTACCCTGTTA----ACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG
P12 TTTAAACTACGGGATCCATTACCCTGTTATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG
P13 TTTAAACTACGGGATCCATTACCCTGTTA----ACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG
P14 TTTAAACTACGGGATCCATTACCCTGTTATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG
P15 TTTAAACTACGGGATCCATTACCCTGTTAT----CAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG
P16 TTTAAACTACGGGATCCATTACCCTGTTATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG
P17 TTTAAACTACGGGATCCATTACCCTGTTATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG
P18 TTTAAACTACGGGATCCATTACCCTGTTATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG
P19 TTTAAACTACGGGATCCATTACCCTGTTATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG
P20 TTTAAACTACGGGATCCATTACCCTGTTATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG
P21 TTTAAACTACGGGATCCATTACCCTG----ATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG
P22 TTTAAACTACGGGATCCATTACCCTGTTATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG
P23 TTTAAACTACGGGATCCATTACCCTGTTATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG
P24 TTTAAACTACGGGATCCATTACCCTGTTATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG
P25 TTTAAACTACGGGATCCATTACCCTG----ATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG
P26 TTTAAACTACGGGATCCATTACCCTG--TATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG
P27 TTTAAACTACGGGATCCATTACCCTGTTATAACAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG
P28 TTTAAACTACGGGATCCATTACCCTGTTAT----CAGGGTAATCCCGGGTACCGGTCGCCACCATGGCCTCCTCCG
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effect on the repair of the Sce-I induced break on the hESCs (Figure 6-5C). Thus, in
hESCs PARP-1 did not affect the properties or frequency of NHEJ repair. This data
correlates with previously published experiments in mESCs where PARP-1 deficient cells
were shown to have the same HRR and NHEJ repair levels as wild type cells (Yang et al.
2004).
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Figure 6-5. PARPi induces DSBs in hESC but does not
contribute to NHEJ. (A) Images and (B) graphical depiction of γH2AX foci in hESCs and NPs after cells were treated with PARPi at 3
μM for 16 hrs. (C) BG01V/NHEJ-red cells were treated with PARPi
for 16 h and collected at 24 h after Ad-SceI infection. (Columns)
Relative NHEJ levels was normalized to β-actin; (Error bars) SEM for
data sets n = 3. No statistical significance was found between treated
and untreated sample.
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Discussion

Our previous results suggest that ATM plays a critical role in the formation and
maintenance of repair foci in astrocytes. Furthermore, treatment of astrocytes with DNAPKi in part inhibited the rate of IRIF resolution. This finding indicates that while DNAPKcs is involved in later steps after marking the DNA break, ATM is vital for the initial
signaling, formation and maintenance of repair complexes necessary for efficient DSB
repair.

Current discoveries show that there may be more than one type of NHEJ, with the
predominant pathway utilizing DNA-PKcs and backup pathway utilizing Histone H1,
PARP-1, and a Ligase III/XRCC1 complex (Iliakis 2009 ). This backup pathway appears
to be inhibited by proteins other than those in the more commonly recognized D-NHEJ
pathway such as Ku70/80 and DNA-PK (Bennardo et al. 2008). It is possible that there is
a change in the pathways as cells differentiate and the backup form of repair is more
prevalent in embryonic stem cells. Interestingly, we show DSBs caused by the
endonuclease I-SceI are repaired in hESCs with greater fidelity than NPs, astrocytes and
glioma cells. It is also apparent that the extent of high fidelity NHEJ decreases through
differentiation. This data is supported by the down regulation of the mRNA of many DNA
damage response proteins as cells differentiate, indicating that repair factors are expressed
differently through differentiation (Maynard et al. 2008).
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Since the hESCs have slower repair kinetics this may indicate that B-NHEJ is used
since for the B-NHEJ repair kinetics is slower than in the D-NHEJ (Iliakis 2009). In
addition the B-NHEJ pathway occurs more often in the S/G2 phase of the cell cycle or in
cells rapidly proliferating (Wu et al. 2008). It is well established by our data as well as
others that hESCs are predominantly in the S/G2 phase of the cell cycle and do not have a
functional G1 checkpoint (Becker et al. 2006). This checkpoint does however become
prevalent in the NP stage of the cell cycle. We have also shown inhibitors of DNA-PK and
ATM are more potent in terminally differentiated cells. These inhibitors may be
ineffective since the backup pathways may not utilize DNA-PK, which interacts directly
with ATM. Also the utilization of the backup pathway with slower kinetics may allow for
polymerases such as µ and λ to fill in nucleotide overhangs and ensure a higher accuracy
of repair. This is corroborated with the increase in fidelity of hESCs compared to
astrocytes. An explanation for high fidelity NHEJ in S or G2 cells is the presence of a
sister chromatid. There is data showing close physical cohesion of sister chromatids that
might play an important role in stabilizing the ends of the DSB and preventing degradation
or exonuclease activity that leads to deletions in NHEJ (Miyazaki and Orr-Weaver 1994).

It was not surprising that PARPi had no effect alone or in combination with ATMi
on NHEJ in hESC since this observation was made in mESCs previously (Yang et al.
2004). PARP-1 exerts its effects by modifying chromatin factors, such as Histone 1, at
single or double strand breaks to enhance repair (Rosidi et al. 2008). One possible
explanation for the lack of an effect of ATMi and DNA-PKi in hESCs is that ESCs are
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globally euchromatic and have elevated global transcription compared to NPs (Meshorer et
al. 2006; Efroni et al. 2008). Therefore, they would not require modification of chromatin
for repair. We have previously shown that the ATR is able to commandeer ATM’s role in
DSB repair signaling in hESCs (Adams et al.) and similarly, ATM may only be required
for a subset of DSBs associated with heterochromatin (Goodarzi et al. 2008). In summary
this data shows that hESC may employ the use of “HiFi” NHEJ in which PARP-1 or
DNA-PKcs does not control factors responsible for nucleotide microhomology fill-in or
resealing.
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Chapter 7 Conclusions

Understanding genomic stability has not only been imperative for developing
cancer therapeutics such as the ATMi and DNA-PKi but is now becoming a focus for
regenerative medicine. Observations that stem cells develop aneuploidy in vitro and that
stem cell transplants can result in aberrant cell signaling leading to tumor formation
provide clinical application to studies investigating these cell’s DNA damage responses
(Amariglio et al. 2009). Previous studies show the spontaneous rate of mutation is
decreased in embryonic cell lines compared to differentiated progeny (Cervantes et al.
2002; Hong et al. 2007). The DSB is the most lethal from of DNA damage and leads to a
massive cellular response. The aim of this study was to advance current perspectives as to
how cells orchestrate the DNA DSB damage response from the embryonic state and from a
terminally differentiated state.
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Initial experiments were aimed at developing methods for analyzing cells
throughout differentiation. We combined both others work through in vitro and in vivo
methods to direct embryonic stem cells to neural NPs and then to astrocytes (Seth et al.
2004; Lawrence et al. 2006; Dhara et al. 2008b). As cells differentiated there was a
decrease in the rates of proliferation, indicating that there were fewer cells in S and G2.
Initial repair studies provided the methods and relevant doses of irradiation to accurately
study repair in ESCs. Here we observed that while hESCs were predominantly in the S
and G2 phase of the cell cycle, they lacked a G1 checkpoint, which has also been observed
in primate and mESCs as well (Koledova et al.; Fluckiger et al. 2006). It is likely that
hESCs would therefore utilize HRR as a main mechanism of DSB repair since HRR is
considered to be most important in the late S and G2 phases (Rothkamm and Lobrich
2003). Therefore this system analyzes the effects of epigenetic and cell cycle effects on
repair since all cell populations are identical at the genetic level.

In order to test this hypothesis both the IRIF repair kinetics of γ-H2AX and
RAD51 were analyzed. hESCs showed a slower rate of resolution of the IRIF. This delay
in resolution is likely due to the form of repair and cell cycle checkpoints status. To
directly look at the use of HRR the cells RAD51 foci formation and resolution were
observed. Here we show a strong dependence of hESCs on HRR which diminishes upon
differentiation. This corroborates the γ-H2AX IRIF resolution because HRR is a more
intricate and slower form of DSB repair.
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The most exciting finding was that ATM seems to not be important in the
resolution of DSBs in hESCs, but becomes imperative for repair in astrocytes. This was
displayed by showing that ATMi rapidly dissolves repair foci in astrocytes but has no
effect on hESCs. In astrocytes it was possible that the repair was occurring faster in ATMi
treated samples since the foci disappeared at a faster rate than those not exposed to drug.
However, by adding the drug before and after IR we showed that this is not the case.
Since ATM was not needed for repair it was possible that ATR was the more important
DNA repair signaling kinase in this cell system. One possible reason for this is that ATR
has repeatedly been shown to be important for initial signaling after replication forks stall
leading to DSBs. Also ATR is an essential gene whereas ATM is not, indicating a more
vital role during development.

Similarly, cell cycle features point to a role for ATR-dependent DSB repair. ATR
is more strongly linked to the G2/M checkpoint which is robust in hESCs, while ATM
correlates with initiating the G1 checkpoint which is absent in these cells. It is possible
that ATM activity is repressed causing a G1 deficiency in hESCs and ATR still facilitates
signaling for hESCs which are predominantly in S/G2. It is important to note others have
demonstrated that ATM is not entirely dispensable in ESCs since it has roles in regulating
cell survival and telomere length (Song et al.). When hESCs are exposed to IR they do
not pause at the G1/S checkpoint but instead continue through the S-phase replicating their
DNA. This phenomenon is known as radio-resistant DNA synthesis, which is also a
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property of cells with ATM mutations or deletions (Abraham 2001). As mentioned earlier,
A-T cells show strong G2 checkpoint signaling regardless of the type of damage unless the
insult occurs in cells already in G2 (Beamish and Lavin 1994). The cell cycle data shown
here therefore supports the idea that hESCs are similar to A-T cells.

Finally it is likely that ATR is responsible for the signaling in hESCs since ATR
and ATM have been shown to act as backup kinases for each other in specific contexts
(Abraham 2001). Currently there are no small molecule inhibitors that target ATR;
therefore it was necessary to examine the effects of inhibition on ATR by siRNA. ATR
was reduced by siRNA treatment and a reduction in γH2AX was observed. This is the
first report of ATR being the main kinase responsible for IR induced DSB repair.
However, using the specific inhibitors we showed that DNA-PK and ATM were crucial for
IRIF resolution in NPs and astrocytes. While ATM inhibition caused disabling of the
repair complexes, the DNA-PK inhibitor only inhibits resolution after the repair complex
formation indicating ATM acts upstream of DNA-PK.

To verify these findings and further explore the role of NHEJ in hESCs we
modified a previously described repair assay (Willers et al. 2006). This is the first time
direct evidence shows by a defined cassette that Oct3/4+ ESCs utilize NHEJ as a repair
mechanism. Using the cassette it was also possible to examine the kinetics of DSB repair
through NHEJ exclusively through PCR assays or by examining DsRed fluorescence.
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Here we saw a significant difference between hESCs and astrocytes in formation of the
PCR product after NHEJ and a greater percentage of cells producing DsRed fluorescence
in the astrocytes as compared to stem cells. Utilizing the specific ATM and DNA-PK
inhibitors we show that the drugs increase their inhibition of NHEJ as cells progress to
terminal differentiation. This is expected due to the previous data showing that resolution
of repair was completely independent of ATM activity. This raises the question, what is
involved in the initial signaling for NHEJ repair? Current dogma holds that ATR is only
imperative for HRR while ATM is involved in signaling for both pathways, however it is
likely that ATR activation affects proteins involved in NHEJ (Valerie and Povirk 2003;
Wang et al. 2004). It is important to note that ATR was recently shown to direct
nucleotide excision repair in S phase cells (Auclair et al. 2008).

We have also devised the repair assay to allow for an easy readout as to the extent
of high fidelity NHEJ by PsiI digestion. This assay is the first to quantify the extent to
which the fidelity of NHEJ deceases as cells differentiate. This may be counter intuitive
seeing as the astrocytes only have NHEJ as a form of repair, but what may be most
important is the fast ligation of the DNA ends back together, rather than the maintenance
of genomic integrity since they will not divide. The fact that hESCs repair their DNA with
greater fidelity is also supported by the cloning of individual PCR products and sequencing
which shows a greater number of sequences in hESCs that have increased repair fidelity in
NHEJ.
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It is thought that hESCs require the highest fidelity of DNA repair given
that they will produce all cells of the organism. Two other factors, apoptosis and cell cycle
checkpoints, are very important regarding the maintenance genetic information. Others
have shown that these hESCs are exquisitely sensitive and readily undergo apoptosis as a
means to clear damaged cells and maintain those with pristine genetic material (Hong et al.
2007; Stambrook 2007). This study also defines not only the cell cycle checkpoint
mechanisms but why there may be an abrogated G1 checkpoint. Since cells are able to
continue and cycle through the S and G2 stages there will be a sister chromatid available to
either allow for homologous sequence to be used for HRR or stabilize the break so “HiFi”
NHEJ is able to take place. Also, proteins involved in the high fidelity forms of repair
may be upregulated in the S and G2 phases of the cell cycle (Branzei and Foiani 2008).

Altogether our results have shown that hESCs rely heavily on HRR in addition to a
high fidelity form of NHEJ which fills in nucleotide overhangs to maintain genomic
integrity. This indicates that stem cells utilize the most accurate mechanisms possible to
maintain genomic stability. Not only is there a strong dependence on HRR which is able to
make a perfect copy of the DNA that was damaged from a homologous sequence, but also
does not depend on DNA-PKcs for NHEJ. This repair shows slower repair kinetics and a
higher degree of repair fidelity. This increased repair fidelity is probably due to
polymerases that are able to fill in slight overhangs caused by the damaging agent.
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